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CHAPTER 1 
Introduction 

INTRODUCTION 
α-CrystaIlin is one of the major vertebrate eye lens proteins. It is usually isolated in the 
form of large water-soluble aggregates with an average molecular mass of 800,000 Da. 
The aggregate consists of two types of subunits, aA- and aB-crystallin (173 and 17S 
amino acid residues, respectively). In rodents a product of alternative splicing, аАш, 
forms part of the aggregate. The two subunits show 37% sequence homology. 
Already in the nineteenth century, Mömer [1] was able to isolate or-crystallin from bovine 
lenses. Much later, the amino acid sequences of aA and aB of numerous vertebrate 
species were determined [2-4], and in 1982 it was found that the or-crystallin subunits are 
homologous with the ubiquitous small heat shock proteins (HSPs) [5]. Until 1989 
α-crystallin was considered as a typical lens-specific structural protein. However, in that 
year, it was discovered by several research groups that aB-crystallin also occurs outside 
the lens, notably in heart, striated muscle and kidney [6-8]. In 1991, Kato and co-workers 
were able to detect very small amounts of αΑ-crystaUin in non-lens tissues [9]. Klemenz 
and co-workers showed in 1991 that aB-crystallin in NIH 3T3 cells behaves in several 
ways like the small HSPs [10]. In this context it is interesting to realize that a lot of other 
crystalline, which are very abundant in the lens, are also present, but at much lower 
concentrations, in many other tissues, where they function as housekeeping enzymes 
[11-15]. With these findings, the lens-specificity and strictly structural nature of all 
crystallins is no longer valid. It is now assumed that normal metabolic proteins were 
recruited as components of the lens fibers during the evolution of the eye, to serve a 
structural role in the lens, rather than playing their normal metabolic role. Their physical 
properties seem to allow association into a highly transparent structure. 
From the above it follows that in the course of time the character of α-crystallin research, 
starting with the view that α-crystallin is a lens-structural protein and finally showing that 
aB-crystallin is a small HSP, has strongly evolved. Some functional aspects of α-crys­
tallin, particularly as an extralenticular protein and its relation to the small HSPs, are 
summarized in the following paragraphs. Additionally, a more elaborate overview of the 
research concerning α-crystallin structure is given. 
THE FUNCTION OF a-CRYSTALLIN 
AND ITS RELATION TO THE SMALL HSPS 
Since the discoveries that the a-crystallins 
are structurally related to the small HSPs 
[4, 5, 16] and that aB-crystallin expression 
is not restricted to the lens [6-8], a number 
of papers appeared on the extralenticular 
role of aB-crystallin in normal and dis­
eased tissues. In the meantime, many 
reports on the functional aspects of the 
small HSPs were published, so that gradu­
ally more insight in the role of ex­
tralenticular α-crystallin and of the small 
HSPs is gained. In this part of the intro­
duction a short summary will be given on 
the structural and functional relationship 
between α-crystallin, especially aB, and 
the small HSPs. For a more complete 
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overview of this extensive field of re­
search, the reader is referred to a recent 
review [171. 
or-Crystallin outside the lens 
aA- as well as aB-crystallin occurs in 
tissues outside the lens. The highest levels 
of aB-crystallin are reached in heart, 
striated muscle and kidney. Up to 5% of 
soluble aB-crystallin is found in rat soleus 
muscle [18]. The highest levels of aA-
crystallin -17 ng/mg- are detected in rat 
spleen [9]. 
Small heat shock proteins 
The small HSPs form one of the four 
major groups of heat shock or stress pro­
teins. The three larger groups of HSPs 
(60, 70 and 90 kDa) are known to be 
molecular chaperones [19, 20]. They are 
helpful in the folding and translocation of 
polypeptides, especially in stress situa­
tions, when their genes are induced. The 
function of the small HSPs is less clear, 
although there is growing evidence that 
they too are engaged in protein-protein 
interactions. Several studies have sug­
gested that the small HSPs are responsible 
for acquired thermotolerance [21-24]. On 
the other hand, no effect of inactivation of 
the yeast HSP27 gene on temperature-
sensitivity and thermotolerance develop­
ment could be detected [25, 26]. The small 
HSPs form a diverse family of proteins 
(15-30 kDa) but they all tend to aggregate. 
Different organisms have a different num­
ber of small HSPs, ranging from 1 in 
yeast and chicken [26, 27] to about 30 in 
higher plants [28]. 
Structural similarities of the small HSPs 
and the a-crystallins 
The a-crystallins and the small HSPs are 
members of a gene superfamily [4, 29]. 
This is based on a conserved homologous 
sequence of 90-100 amino acid residues. 
This gene superfamily also includes two 
mycobacterial surface antigens and a major 
egg antigen of Schistosoma monsoni. The 
sequence homology is most pronounced in 
the C-terminal parts of the polypeptides, 
corresponding with the putative globular 
C-terminal domain of a-crystallin [30]. 
a-Crystallin residues which have been sug­
gested to be of structural importance [30] 
are very well conserved in the entire fami­
ly. The N-terminal regions vary in length, 
and sequence homology cannot be detec­
ted. 
It was recently shown that the secondary 
structure of calf a-crystallin and mouse 
HSP25 are very similar, both proteins 
having primarily /9-sheet conformation 
[31]. Also hydrophobicity similarities of 
the homologous region of a-crystallin and 
the small HSPs have often been noticed 
[4. 16]. 
Both α-crystallins and the small HSPs 
form large aggregates. a-Crystallin is 
mostly isolated as 800 kDa aggregates, but 
complexes, ranging in size from 280 to 
10,000 kDa have been isolated as well 
[32, 33]. Also small HSP aggregates differ 
in size, ranging from 180 kDa for chicken 
[34] to 400-800 kDa for mammalian small 
HSPs [35]. Upon stress, aB-crystallin in 
heart forms larger aggregates [36]. Also 
small HSP aggregates increase in size 
upon stress in various cell types [e.g. 
35, 37]. Often, concomitantly, the small 
HSPs redistribute from the cytoplasm 
towards the perinuclear region or into the 
nucleus [35, 38]. This phenomenon has 
also been observed with aB-crystallin in 
mammalian cells [10, 39, 40]. In all cases 
redistribution back to the cytoplasm occurs 
during recovery. Mixed aggregates of aB-
crystallin and small HSPs have been ob­
served in vivo [41, 42]. In the electron 
microscope both a-crystallin and the small 
HSPs appear as 10-18 nm globular, some­
times torus-like or hollow-core particles 
[37, 4345]. 
Like for a-crystallin, the arrangement of 
subunits within the small HSP aggregate 
remains unclear. Several models for the 
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quaternary structure of α-crystallin have 
been proposed (see later in this introduc­
tion). For mouse HSP2S a sphere-like 
structure composed of about 32 monomers, 
arranged in hexagonal packing, has been 
proposed [45]. 
Gene structure, expression and regu­
lation 
The aA- and aB-crystallin genes, located 
on the human chromosome 21 and 11, 
respectively [46, 47], contain two introns 
at homologous positions. The first intron 
coincides precisely with the intron in the 
small HSPs genes of Caenorhabditis ele-
gans. Most other small HSPs are encoded 
by intronless genes. The 5' flanking re­
gions of the small HSP genes and of the 
aB-crystallin gene contain one or more 
heat shock elements. As a consequence 
these genes can be induced by elevated 
temperatures and various other types of 
stress [10, 48, 49]. Additionally, the small 
HSP and aB-crystallin genes are induced 
at specific stages during normal develop­
ment [e.g. 18, 43, SO, 51]. Small HSP 
genes can also be induced by estrogen [52] 
and ecdysteroids [48]. Interestingly, aB-
crystallin accumulation in NIH 3T3 cells is 
brought about by dexamethasone-induction 
of v-mos and the Ha-ras oncogenes 
[10. 53, 54]. 
Some functional aspects 
A major common feature of a-crystallin 
and small HSPs is their phosphorylation on 
specific serine residues. The phosphoryla­
tions of the α-crystallin subunits are most 
likely catalysed by a cAMP-dependent 
kinase [55, 56]. Phosphorylation in the 
lens epithelium is thought to be reversible 
[57]. Also in other tissues aB-crystallin 
can be phosphorylated, like in mouse heart 
and in Alexander's disease brain [58]. The 
reversibility of the phosphorylation of 
α-crystallin suggests that it is part of some 
regulatory mechanism. Phosphorylation of 
small HSPs is more evidently subject to 
metabolic control. Phosphorylation of 
mammalian small HSPs occurs in response 
to a number of mitogenic and environmen­
tal stimuli [59-62]. Phosphorylation of 
human HSP27 occurs after activation of 
platelets by thrombin [63] and after heat 
shock [64, 65]. 
aB-Crystallin appears to have a role in 
cells that undergo major cytomorphological 
reorganizations in early chicken embryoge-
nesis [66]. Likewise, HSP27 of Drosophila 
is abundant during embryogenesis [43]. 
Additionally, both the small HSPs and aB-
crystallin are found to be involved in 
intracellular changes during disease pro­
gression [e.g. 67, 68]. aB-Crystallin is 
involved in reactive processes of astrocytes 
and oligodendrocytes in the central ner­
vous system [69], in the development of 
benign tumors associated with tuberous 
sclerosis [70], in the development of astro­
cytic tumors [71] and it is a major com­
ponent of ubiquitinated inclusion bodies in 
human degenerative diseases [72]. In these 
inclusions aB-crystallin is tightly as­
sociated with intermediate filaments and 
ubiquitin [73]. Likewise, small HSP ex­
pression seems to be differentially regu­
lated in tumor development [74-76]. It thus 
appears that aB-crystallin as well as the 
small HSPs are involved in cellular rear­
rangements during normal development 
and disease progression. 
In this context it should be mentioned that 
there are many examples of the interaction 
of α-crystallin and the small HSPs with 
membranes and other proteins. Native 
α-crystallin associates specifically with 
lens membranes [77, 78] and the lens fiber 
cytoskeleton, notably the intermediate 
filaments [79, 80]. Additionally, aB-crys­
tallin interacts specifically with actin in 
heart [36] and associates with desmin in 
rat myocytes [44]. Plant chloroplast small 
HSPs become associated with the thylakoid 
membranes after heat shock [81, 82]. 
Cytoplasmic plant small HSPs associate 
with the cytoskeleton during heat 
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shock [83]. 
Recent in vitro experiments have shown 
that both or-crystallin and mouse HSP2S 
can act like molecular chaperones 
[31, 84, 85]. This and the fact that or-crys­
tallin and the small HSPs are involved in 
cytomorphological rearrangements and that 
they interact with membranes and proteins 
in vivo, suggest that or-crystallin and the 
small HSPs might be molecular chaperones 
in vivo, as well. The recruitment of or-
It is now well known that the occurrence 
of or-crystallin is not restricted to the lens 
and that its function is not strictly struc­
tural. However, most of the studies of or-
crystallin structure were done at the time 
that or-crystallin was considered to be a 
lens-specific structural protein. a-Crystal-
lin structural studies were done in the 
context of lens transparency. To achieve 
transparency, light-scattering must be 
reduced to a minimum. Lens membranes 
are therefore closely packed and regularly 
spaced. Cell organelles, such as nucleus, 
mitochondria and endoplasmatic reticulum 
are lost upon terminal differentiation of the 
elongating fiber cells. Consequently, there 
is no significant transcriptional- and trans-
lational activity in the deeper layers of the 
lens. High protein concentrations are 
needed to generate a refractive index 
gradient for proper light-focusing. Protein 
concentrations in the lens are so high (up 
to 60% of the lens wet weight) that 
through short-range interprotein interac­
tions a regular ordening in the position of 
near-neighbour proteins is produced, resul­
ting in a perfectly clear lens with optimal 
reduction of light-scattering [86]. 
From the above it is obvious that strict 
demands are made on lens proteins. They 
should be stable, highly soluble, and have 
a structure that results in close packing 
crystallin as a major lens protein now be­
comes also understandable. Its intrinsic 
structural stability makes it suitable to 
reside life-long, without turnover, in the 
lens. By preventing undesirable protein 
interactions and refolding unfolded pro­
teins it would contribute to the mainte­
nance of lens transparency and integrity. 
In fact, the constitutively high level of a-
crystallin in the lens might make it per­
manently stress-tolerant. 
and regular ordening. To better understand 
the architecture of the eye lens, it is there­
fore crucial to know the three-dimensional 
structure of the crystallins. The first crys­
tallin for which the crystal structure was 
solved is the γΒ-crystallin monomer in 
1981 [8η, followed by >C in 1986 [88], 
γΕ in 1989 [89] and the /3B2 homodimer 
in 1990 [90]. All these crystallins, which 
are members of one ß/y crystallin family, 
are comprised of two globular domains, 
each folded in two symmetrically orga-
nized Greek key motifs. Also the organiza-
tion of the 0-crystalhn oligomers becomes 
more and more clear. It is known how the 
subunits in the /3B2 homodimer are inter-
acting, and a computer model of the 
0A4//SB2 heterodimer has also been built 
[91]. 
Unfortunately, the tertiary structure of the 
or-crystallin subunits and the organization 
of the subunits within the aggregate are 
poorly understood. Many attempts have 
been made to crystallize or-crystallin, how-
ever no or-crystallin crystals could be 
obtained up till now, probably because of 
the polydisperse nature of the aggregate 
[92]. Not only is the or-crystallin aggregate 
composed of two types of primary gene 
products, oA and orB, but also several 
posttranslationally modified products 
[e.g. 56,93-96] form part of the ag-
THE STRUCTURE OF a-CRYSTALLIN 
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gregate. Structural studies are therefore 
dealing with a rather complex protein ag­
gregate. 
of-Crystallin mainly contains j3-pleated 
sheets and almost no α-helices [97-99], as 
shown by CD spectroscopy. As stated 
before, the tertiary structure is not known, 
but several hypothetical models have been 
suggested. Some of them are based on the 
principle that three-dimensional structure 
similarity can be achieved with very little 
sequence homology. On basis of hydro­
phobic residue alignment of a- and ß/y-
crystallins, or-crystallin has been proposed 
to consist of six folding units, arranged in 
a two- or three-domain structure [100]. 
Argos and Siezen then compared a-crystal-
lin with the 0/7-crystallins with regard to 
'surrounding' hydrophobicity, rum prefe-
rence and anti-parallel strand potential. 
This resulted in a four-motif structure for 
the α-crystallin subunits [101]. This model 
was endorsed by hydropathy prediction 
plots [102], far UV CD measurements and 
secondary structure predictions [97]. Wis-
tow proposed the overall structure of 
or-crystallin to consist of a globular N-ter-
minal domain of two symmetry-related 
motifs and a somewhat larger C-terminal 
domain, also of two motifs, with an ex­
posed C-terminal arm [30]. This model is 
based on the gene structure and internal 
homology of αΑ-crystallin. The N-ter-
minal domain corresponds with exon 1, 
whereas the entire C-terminal region is 
encoded by exons 2 and 3. The C-terminal 
globular domain is common also to the 
small heat shock proteins and might be the 
result of duplication of a gene encoding an 
ancestral 30-40 residue protein. The con­
served C-terminal domain probably repre­
sents an extremely thermodynamically 
stable structure which predated the lens, 
and was used to build a protein capable of 
surviving for years without turnover in the 
lens. Indeed α-crystallin is remarkably 
thermostable [103, 104]. Also the small 
HSPs are reported to be very stable in vivo 
[61]. Ingolla and Craig, however, pos­
tulated that this region of homology bet­
ween α-crystallin and the small HSPs is an 
'aggregation' domain [5], since also the 
small HSPs form -800 kDa aggregates. 
Also for the quaternary structure of a-
crystallin, several models have been pro­
posed. Bindels et al. introduced a 'three-
layer model' [105]. This model is mainly 
based on studies that imply three different 
environments for the α-crystallin subunits. 
By measuring reactivity of sulphydryl 
groups to various reagents the observation 
was made that three classes of aA subunits 
exist, with respect to their position in the 
aggregate, namely surface exposed, par­
tially exposed and totally buried [106]. 
This finding was later supported by a 
surface probing study in which α-crystallin 
lysine residues were modified by citraconic 
anhydride [107]. 
Bifunctional crosslinking experiments 
revealed a gradual decrease in intensity 
going from monomers to higher oligomers, 
suggesting that α-crystallin aggregates are 
not likely to be built up of smaller clusters 
such as trimers or tetramere. Not all sub-
units could be linked to each other, pro­
bably because some subunits are buried in 
the anterior of the aggregates [105, 108]. 
Electron microscopy, sedimentation analy­
sis and small-angle X-ray scattering de­
monstrated that both native and reasso-
ciated α-crystallin are heterogeneous popu­
lations of spherical or slightly ellipsoidal 
molecules with diameters of —15 nm for 
native α-crystallin and —10 nm for reas-
sociated α-crystallin [92, 109]. Partial 
dissociation in urea pointed to a stepwise 
dissociation of subunits, implicating the 
existence of multiple layers [105]. Limited 
in vitro proteolysis experiments revealed 
that all or nearly all aB-crystallin subunits 
are cleaved, suggesting that most B-chains 
are surface exposed and are likely to be in 
equivalent positions [110]. After aB-crys­
tallin cleavage, αΑ-crystallin subunits are 
cleaved, but not at the same rate, indica-
m 
υ 
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ting that the orA subunits are in different 
environments. The above mentioned obser­
vations finally led to the three-layer 
model for the quaternary structure of 
a-crystallin (Fig. 1A). In this model the 
a-crystallin aggregate consists of three 
concentric layers of subunits. The core 
consists of 13 A chains, arranged in the 
way shown in Fig. 1A-1. The next 14 
chains, 10 A and 4 В chains, may form a 
layer in between (Fig. 1A-2), while the 
remaining chains, 8 A and 8 В cluuns, are 
located in the outer layer (Fig. 1A-3). This 
model holds 43 subunits, with places still 
unoccupied in the outer layer; with all 
open places occupied (Fig. 1A-4), the 
model contains 51 subunits. This model 
explains the observed different environ­
ments for the subunits. It also accounts for 
the molecular weight of 1-1.1x10* found 
for nuclear a-crystallin, while the larger 
aggregates are supposed to be the result of 
linear polymerization [IOS]. 
By means of sedimentation analysis and 
electron microscopy the effects of alkaline 
pH, ionic strength, temperature and cal­
cium ion concentration on the quaternary 
structure were studied [111]. A complex 
hypothetical scheme of transitions of bo­
vine α-crystallin, caused by changes in 
these physicochemical parameters, was 
introduced. In this model the transitions 
can be easily explained with the three-
layer model, being the result of partial 
dissociation of the consecutive layers. To 
endorse the three-layer model several other 
experiments, like fluorescence and near 
UV CD measurements, were done [112]. 
The spectroscopic signals parallelled chan­
ges in sedimentation coefficient upon 
increase of dénaturant concentration, 
which was explained in terms of aromatic 
residues getting exposed upon dissociation 
to 12S intermediates. This suggests the 
existence of a two-layer 12S intermediate 
and thus supports the three-layer model. 
Although the evidence for the three-layer 
model seems to be rather convincing, it 
was questioned by Thomson and August-
eyn [113, 114]. The three-layer model is 
based on the assumption that the at low 
temperature isolated ac-crystallin, the 600-
Rg. 1: Models for the quaterna!; structure of e-trystallin. Panel A: Three-layer model of Bindels et aL 
[105]. The core (A-l) is composed of 13 A chains (while epherea). The second layer (A-2) contains 14 not 
fully solvent-exposed subunits; 10 A chains and 4 В chains (black spheres). The outer layer (A-3) has 8 A 
and 8 В chains that are maximally solvent exposed. This model holds 43 subunits, corresponding with the 
molecular mass of o
c
-crystallm ( ± 800 IcDa) of a-crystallin. The outer layer contains open places that can 
be filled with additional subunits (A-4), resulting in a total of 51 subunits. Panel B: Three-layer model of 
Tardieu et al. [116], seen from a three-fold axis. The first layer (B-l) is made up of 12 A chains (grey 
spheres). The second layer (B-2) accomodates 24 subunits (white spheres), and the 12 equivalent sites of the 
third layer (B-3) are filled (black spheres) to yield a 48 subunit particle. This model is symmetrical and has 
a limited number of different subunit-subunit contacts. Two types of sites are present m the second and third 
layers, so two types of subunits may be acromndatfd in these layers. Panel C: Micellar three-layer model 
of Walsh et al. (104). The innermost layer (C-l) is a micelle, consisting of 12 subunits, arranged in 
cuboctahedral symmetry. The apolar region (black) is directed inward, constituting a hydrophobic core. A 
second layer (C-2) consists of αχ subunits, directing their apolar faces toward the hydrophobic core. These 
two layers constitute a micelle-like structure with octahedral symmetry. The thud layer (С-Э) adds more 
subunits up to a total of not more than 24. The model, exhibiting cuboctahedral symmetry contains 42 
subunits, corresponding to the molecular mass of a
c
-crystailin (±800 IcDa). Panel D: Quaternary structure 
model by Wistow [139]. Two possible isoforms of cr-crystallin are presented: the cube (D-l) and the 
rhombic dodecahedron (D-2). In both isoforms each face consists of the C-temunal domains of four subunits 
(forming a tetramer), whereas the N-temunal domains are directed towards the interior. Each domain 
(indicated by a peanut-shape) in the tetramer interacts through identical a-b interactions. Tetramers associate 
by identical c-d interactions. The cube has 6 faces and hence 24 subunits. The rhombic dodecahedron has 12 
faces and consists of 48 subunits. 
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1000 kDa aggregate, is the in vivo forni of 
a-crystallin. Dissociation of a
c
 at low urea 
concentrations resulted in a relatively 
stable smaller aggregate, considered to 
represent the inner two layers [112]. 
Thomson and Augusteyn, however, con­
sidered the low molecular mass aggregate, 
a
m
 as the native in vivo situation. Their 
point of view was based on studies in 
which it was shown that at 37°C, better 
approaching the in vivo situation, a-crys­
tallin is isolated as a 12S (320,000 Da) 
particle, whereas at 5°C it is isolated as a 
17S (635,000 Da) particle. Additionally, 
they showed that dissociation of α,,,-crys-
tallin is completely reversible, which was 
interpreted as an indication that a
m
 is the 
native state. However, van den Oetelaar et 
al. showed that at 37°C, but under more 
physiological conditions concerning pH 
and ionic strength, still the larger ag­
gregates (-800 kDa) are isolated [115]. 
The controversy, which one of the oligo­
mers, or
e
 or a
m
, is the in vivo form of 
a-crystallin, prompted Tardieu and co­
workers to reexamine the three-layer 
model [116]. By means of X-ray and quasi 
electric light scattering they measured 
several hydrodynamic parameters of o-
crystallin particles under varying con­
ditions (pH, ionic strength and tempera­
ture]. The three-layer model, based on or
c 
being the native form of a-crystallin, 
appeared compatible with the experimental 
data. By applying basic principles of sym­
metry and by minimizing the number of 
different contacts between protein sub-
units, a three-layer model with tetrahedral 
symmetry was built (Fig. IB). The core 
consists of 12 (Fig 1B-1), the second and 
third layer of 24 subunits each (Fig 1B-2, 
3). The second and third layers possess 
two types of sites and can thus accomodate 
two types of subunits, aA and aB. The 
restrictions to minimize the amount of 
different types of subunit contacts and to 
maximize the amount of local contacts 
stabilizing the final structure, leads in­
evitably to probabilities of occupancy for 
the sites in outer layers. This accounts for 
the intrinsic polydispersity of a-crystallin 
and the fact that physicochemical para­
meters influence the aggregate size. The 
loss of subunits from a
c
 by changing 
physicochemical conditions is considered 
as an in vitro artefact, due to non-physio­
logical conditions. 
On basis of various experiments Augus­
teyn and co-workers disagreed with the 
three-layer model [114, 117-120]. They 
argued that the conclusion of Buidels and 
Siezen that the changes occurring between 
1 and 4 M urea represent the progressive 
removal of a middle layer of subunits 
[105] was invalid [114]. Later, this was 
admitted by Bindels et al. [121]. Ad­
ditionally, Augusteyn and co-workers 
demonstrated that there is only one class 
of sulphydryl groups in foetal a-crystallin 
[117], but that conformational changes in 
the protein during ageing give rise to the 
heterogeneity within this class, as was 
observed by Siezen et al. [106]. Further, 
they showed that a-crystallin particles can 
be constructed using any combination of 
purified A and В chains from any species 
[118]. In view of these observations and 
the similarities in sequences [122], im­
munochemical properties [119], and the 
microenvironments of aromatic and other 
amino acids [117, 120], they assumed that 
aA and aB have similar three-dimensional 
structures and consequently can occupy the 
same sites in the aggregate. Indeed, Hen­
driks et al. provided evidence that all three 
subunits in rat a-crystallin occupy equi­
valent positions [123]. Based on the above, 
a dodecamer displaying tetrahedral sym­
metry was suggested for the arrangement 
of subunits. This is consistent with the 
equivalence of subunits, but fails to ex­
plain the variations in size of the particle 
[118]. 
To account for the facts that the a-crystal­
lin aggregate is polydisperse and its size 
distribution is dependent on physicochemi-
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cal parameters [111, 113, 124], Augusteyn 
and Koretz proposed a flexible micelle 
structure with equivalent positions for all 
subunits [125]. By tryptophan fluores­
cence quenching studies it was shown that 
most likely, the N-terminal region is situa­
ted close to the center of the aggregate 
[120, 126]. Hydrophilicity profiles [12η 
suggested that the N-terminal domain is 
hydrophobic, whereas the C-terminal do­
main is more hydrophilic. This suggests 
that the N-terminal domain represents the 
hydrophobic end of the amphiphilic sub-
units, necessary for the formation of mi­
celles. It should be noted, however, that 
the N-terminal domain is predicted to be 
less hydrophobic when another prediction 
method is used (Fig. 2). The possible 
existence of α-crystallin micelles was 
recently validated by means of hydrostatic 
pressure and surface tension experiments 
[128]. With increasing hydrostatic pressure 
the turbidity of an α-crystallin solution 
increases exponentially to a plateau, and 
the surface tension of α-crystallin in a-
queous solution levels off with increasing 
protein subunit concentration, as with 
other amphipathic molecules aggregated 
into a micellar structure. 
The existence of a flexible dynamic ag­
gregate is also endorsed by the finding that 
the subunits are exchanged between ag­
gregates under native conditions [129]. A 
variety of age-dependent changes occur in 
the eye lens. The electrolyte composition, 
which has been shown to influence the 
quaternary structure of α-crystallin 
[111, 115, 116], changes with age 
[130, 131]. α-Crystallin undergoes post-
translational modifications during ageing 
[e.g. 2, 94-96, 132-134]. Due to dehydra­
tion of the bovine lens nucleus, the cellular 
protein concentration increases with age 
[135-137]. These changes might disturb 
the thermodynamic equilibrium of the 
existing α-crystallin population. By inter-
molecular exchange of subunits, new 
thermodynamically stable populations can 
be formed. 
A new model for α-crystallin quaternary 
structure was recently introduced by Walsh 
et al. [104]. The proposed model of native 
α-crystallin has a three-layer structure in 
which the inner layer is a micelle contain­
ing 12 subunits arranged in cuboctahedral 
symmetry (Fig. 1C-1). The apolar region 
is directed inward constituting a hydropho­
bic core similar to a micelle and adding 
Hydropathy 
τ ι I M и« 
Rttldu· Position 
Fig. 2: Hydropathy patterns of bovine aA-
crystallin, generated by two different methods. 
Average hydrophilicity values were calculated for 
each nonapepUde and plotted against the average 
sequence position of the nonapeptide. Negative 
values reflect hydrophilic regions, whereas positive 
values indicate hydrophobic regions. In panel A the 
prediction method of Hopp and Woods [149] was 
used, in panel В that of Kyte and Doolittle [ISO]. 
The two patterns differ in the region 1-50. The 
method of Hopp and Woods predicts this region to 
be hydrophobic, in contrast with the method of 
Kyte and Doolittle, which predicts this region to be 
predominantly hydrophilic 
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structural stability. A second layer consists 
of six subunits with their apolar faces 
directed towards the hydrophobic core 
(Fig.lC-2). The third layer adds more 
subunits up to total of 24 (Fig.lC-3). 
Subunit contacts in the third layer will be 
mostly polar-polar. Two thermal trans­
itions were measured with differential 
scanning calorimetry. They might cor­
respond with the dissociation of the third 
layer that reorients and forms a new two-
layer structure, and the transition of the 
resulting two-layer aggregate into a more 
compact thermodynamically stable struc­
ture. This three-layer model has several 
advantages compared to the model propo­
sed by Tardieu et al. [116]. It better ac­
counts for the irreversibility of the a
e
-*a
m 
transition. Additionally, the molecular 
mass of the two inner layers of the new 
model better corresponds to that of a
m
. 
The disadvantage of both models is that 
they are partly based on the reports that 
bovine α-crystallin contains three different 
classes of sulphydryl groups [106, 138]. 
This finding is contradicted by Augusteyn 
et al. [117]. 
The most recent model for a-crystallin 
quaternary structure was introduced by 
Wistow [139]. It is based on studies of 
Merck et al. [140] and on the assumption 
that among a variety of possible dynamic 
structures at least one stable structure is a 
roughly spherical aggregate of 800-900 
kDa. Merck et al. demonstrated that the 
putative C-terminal domain and tail of aA-
crystallin, which is highly conserved and 
maintains the closest similarity to the small 
HSPs, assembles into tetramers, whereas 
the more hydrophobic N-terminal domain 
forms less defined multimers. The ability 
of the C-terminal domain to tetramerize 
suggests that a tetramer is the fundamental 
building block for larger aggregates with 
four-fold symmetrical faces. One of these, 
the rhombic dodecahedron is proposed to 
be one of the stable forms of a-crystallin. 
In this model all subunits are in equivalent 
positions, although still three levels of 
interaction between subunits exist. The 
outside surface of rhombododecahedric a-
crystallin consists of C-terminal domains, 
explaining its susceptibility towards several 
modifications [2, 94-96, 132-134]. like in 
the micelle model, the core consists of 
mainly N-terminal domains, that probably 
interact rather unspeciñcaüy permitting 
variation in assembly. Finally, changing of 
physicochemical environments may lead to 
alternative quaternary structures, based on 
the same building block, e.g. the fourfold 
faced hexameric cube, with 24 subunits. 
This would explain the existence of 
smaller aggregates. 
It is clear from the above that there is as 
yet absolutely no agreement on the quater-
nary structure of α-crystallin. This may be 
due to the proposed dynamic structure of 
a-crystallin [129, 139]. Moreover, the 
interpretation of structural data is seriously 
hampered by the influence of the isolation 
conditions on several physicochemical 
characteristics [111, 115], although a 
recent study demonstrates that the com­
positions of three different isolation buf­
fers do not affect the properties of a-crys­
tallin [141]. 
The in vivo situation is even more com­
plex. The aggregate size of a-crystallin 
increases upon ageing [32, 142], a pheno­
menon that has been observed in vitro as 
well [143]. Furthermore, the a-crystallin 
aggregates are very heterogeneous, due to 
posttranslarional modifications. These in 
vivo modifications include oxidation, de-
amidation, phosphorylation, racemization, 
chain cleavage, glycation, carbamylation 
and disulfide- and non-disulfide crosslink-
ing [for reviews 93, 142, 144-146]. Many 
of these modifications cause changes in 
charge, size and solubility of a-crystallin, 
resulting in conformational changes, even­
tually leading to cataract formation [for 
reviews 142, 147, 148]. 
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OUTLINE OF THIS THESIS 
In order to better understand the functional and structural relationships between a-crystal-
lin and the small HSPs , we compared several known features of α-crystallin with those 
of the mouse small HSP (chapter 2). To find out what is the importance of the evolution-
arily conserved C-terminal domain of the members of the α-crystallin/small HSP family 
and whether this domain is responsible for the aggregate formation, several studies were 
undertaken. In chapter 3, the aggregation behaviour of the N-terminal domain and 
C-terminal domain and tail of aA-crystallin is described, while in chapter 4 the C-ter­
minal domain and tail of three different members of the protein family are compared with 
regard to aggregation behaviour, secondary structure and heat protection capacity. The 
structure of aA-crystallin was further studied by site-directed mutagenesis (chapter 5). In 
chapter 6, it is reported that leakage of crystallins from the cataractous lens provokes an 
autoimmune response against most β- and γ-crystallins, but not against eA- and orB-
crystallins, reflecting immunological tolerance because of the extralenticular occurrence of 
the latter. 
Knowledge about the structure of α-crystallin will give insight into the interaction 
between proteins in the lens. It would moreover teach us about the interprotein interac­
tions that play a role in the molecular chaperoning of proteins by α-crystallin and the 
small HSPs. 
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Structural and functional similarities of bovine a-crystallin and 
mouse small heat shock protein. 
A family of chaperones 

Structural and functional similarities of bovine a-crystallin and 
mouse small heat shock protein. A family of chaperones. 
o-Crystallin, composed of the subunits oA and aB, is a major vertebrate eye lens protein, accomplishing a 
structural role in maintaining lens stability and transparency. Both subunits also occur in low amounts 
outside the leas, where their precise function is unknown. They are structurally related to the small heat 
shock proteins (HSPs1), and increasing evidence indicates that they have also functional similarities with the 
small HSPs. In order to extend our insight into these structural and functional relationships, the mouse small 
HSP (HSP25) was compared with bovine α-crystallin, with respect to several known properties of the latter. 
We show that α-crystallin and HSP25 resemble each other in secondary structure, and have the same 
stability towards urea dissociation at pH 7.0. Mixed polymers can be formed from any combination of orA-
crystallin, aB-crysttlhn and HSP25 subunits. Furthermore, we demonstrate that HSP2S, like ct-crystallin, 
can function as a molecular chaperone, by suppressing heat-induced aggregation of other proteins, and is an 
efficient inhibitor of elastase. Finally, HSP2S is found to be a substrate for protein crosslinlang by tissue-
type transglutaminase, like aB-crystallin. Our results thus corroborate that a-crystallin and the small HSPs 
have comparable functions, probably being involved in the protection of other proteins under conditions of 
stress 
INTRODUCTION 
Ten years ago it was discovered that the 
Drosophiia small heat shock proteins are 
homologous with the vertebrate eye lens 
protein a-crystallin [1]. This led to the 
suggestion that a-crystallin has evolved 
from a heat shock protein-like ancestor [1, 
2]. While fully enigmatic at the time, 
several recent findings shed light on this 
evolutionary transition of a ubiquitous 
stress protein into a structural lens protein 
[3]. Most revealing has been the discovery 
that the two homologous subunits of 
a-crystallin, aA and aB, until then 
thought to be strictly lens-specific, both 
occur constitutively outside the eye. aB-
Crystallin reaches considerable levels in 
heart, striated muscle and kidney, and is 
present in many other tissues [4-7]. Small 
amounts of αΑ-crystallin are found in 
spleen and thymus [8]. Equally important 
is the demonstration that aB-crystallin 
behaves in several respects like the mam­
malian small HSPs. The expression of aB-
crystallin is induced upon stress [9-11] and 
under certain pathological conditions 
[12-17]. After stress it relocalizes from the 
cytoplasm towards the nucleus [9, 11, 16, 
18]. Apart from the sequence homology, 
which is most pronounced in the C-ter-
minal halves of a-crystallin and small 
HSPs, the proteins also resemble each 
other in their quaternary structure. Both 
form large complexes, usually between 
400 and 800 kDa [19-22], which electron 
microscopically appear as 10 to 18 nm 
globular structures [23-27]. The aggregate 
size of the small heat shock proteins in­
creases during stress [19, 28]. Similarly, 
amorphous aB-crystallin aggregates are 
formed after ischemia [16]. 
To enable a further comparison between 
a-crystallin and small HSPs, we analysed 
1
 The abbreviations used are: HSP, heat shock protein; HSP25, mouse small HSP; SDS, sodium dodecyl 
sulfate; PAGE, Polyacrylamide gel electrophoresis; CBB, Coomassie Brilliant Blue; Bistns, 2,2-
Bisfhydroxymethyl)-2,2' ,2' '-nitnloethanol. 
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some important structural and functional 
features of both proteins. These include 
comparison of secondary structure, dis­
sociation in urea, ability to form mixed ag­
gregates, ability to inhibit elastase [29] and 
the ability to be a substrate for transgluta­
minase [30]. In addition, we examined the 
ability of the mouse small HSP to suppress 
heat-induced aggregation of other proteins, 
a property which was recently shown for 
α-cry stallin [31]. 
MATERIALS AND METHODS 
Isolation of proteins 
α-Crystallin was isolated from the water-
soluble fraction of calf lens cortex by gel 
permeation chromatography [32]. α A- and 
aB-subunits were separated by ion-ex­
change chromatography on DEAE-cel-
lulose [32]. Recombinant mouse HSP2S 
was expressed in E.coli BL21(DE3), using 
the expression clone pAK3038p25, as 
described by Gaestel et al. [33]. The 
mouse HSP25 was purified from the E.coli 
lysate essentially according to Gaestel et 
al. [34]. Recombinant bovine aA-crystallin 
was expressed in E.coli BL21(DE3), as 
described by Merck et al. [35]. αΑ-Crys-
tallin was purified from the E.coli water-
soluble fraction by ion-exchange chromato­
graphy on Fast Flow DEAE-cellulose 
(Pharrnacia-LKB), applying a linear phos­
phate gradient (0.05 M to 0.40 M sodium 
phosphate, pH 6.8). Recombinant aA-
crystallin was only used in the circular 
dichroism experiments. flL-crystallin, used 
in the heat protection assay was obtained 
by gel filtration [32]. 
Circular dichroism measurements 
These were performed using a Jasco 
Model 600 spectropolarimeter. A 0.25 mm 
or 0.50 mm pathlength cell was used. 
Tryptophan fluorescence 
Tryptophan fluorescence was measured on 
samples containing 50-100 pg of protein 
per ml in 50 mM Bistris (pH 6.0 or 7.0) 
and 0.1% 0-mercaptoethanol. The con­
centration of urea in the preparations 
ranged from 0 to 7 M. After at least 2 h 
of incubation at room temperature, fluores­
cence emission spectra were recorded with 
a Hitachi F-3000 spectrofluorometer and 
associated data station, using a 1 cm path-
length quartz cuvette. The spectra were 
recorded over the 300-400 nm range, 
using an excitation wavelength of 295 nm, 
with a 5 nm excitation and a 3 nm emis­
sion slit. All spectra were corrected for the 
solvent used. Transition points were cal­
culated as described by Pace et al. [36]. 
Reaggregation of pure and mixed poly­
peptides 
Various proteins or protein mixtures, 
containing approximately equal amounts of 
each protein, were dissolved in phosphate-
buffered 6 M urea (50 mM sodium phos­
phate, 50 mM NaCl, 1 mM EDTA, 
0.02% 0-mercaptoethanol, pH 7.2), with a 
final protein concentration of about 
1 mg/ml. After 2 h of incubation at room 
temperature, the solutions were diluted to 
a final concentration of 1 M urea with the 
above mentioned phosphate buffer, con­
taining protease inhibitors (2 μg/ml pep-
statin A, 0.1 μΐηοΐ/ml benzamidin, 
1 /ig/ml bacitracin, 2 μg/ml aprotinin, 
2 jig/ml leupeptin and 0.2 μΜ phenyl-
methylsulfonyl fluoride). The urea was 
removed by dialysis at 4°C against de-
ionized water, containing 0.02% 0-mer-
captoethanol. After lyophilization, the 
renatured protein samples were subjected 
to gel permeation analysis or biotinylation 
and immunoprecipitation. 
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Gel permeation analysis 
200-300 μg of the reaggregated proteins or 
protein mixtures were analysed by means 
of FPLC gel permeation chromatography, 
using a Superóse 6 HR 10/30 prepacked 
column (Pharmacia-LKB). The column 
was equilibrated with 50 mM sodium 
phosphate (pH 7.5), 50 mM NaCl and 
1 mM EDTA . The column was eluted at 
room temperature, at a flow rate of 
0.5 ml/min and monitored by absórbanos 
at 280 nm. High molecular weight markers 
from the Pharmacia gel filtration calibra-
tion kit were used. 
Biotinylation and immunoprecipltation 
Before immunoprecipitation, 100-300 μg 
of the reaggregated protein samples were 
labelled with biotin by incubation with 0.2 
mM NHS-LC-biotin (Pierce) for 2 h at 
room temperature in 300 μί biotinylation 
buffer (0.1 M NH4HC03, 0.1 M NaCl, 
pH 8.0). The reaction was stopped by 
addition of 3 μί 1 M Tris/HCl, pH 8.0. 
Immunoprecipitation was performed with 
polyclonal antibodies directed against 
mouse HSP25, bovine α A- and aB-crystal-
lin coupled to protein A Sepharose beads 
(Pharmacia). To that end 100 μί of the 
polyclonal antisera were incubated with 
200 μί of a 50% protein A Sepharose 
beads suspension in coupling buffer 
(10 mM Tris/HAc, pH 8.0, 0.5 M NaCl, 
0.1% Nonidet P-40) during 2 h at 4°C in 
an end-over-end rotator. The beads were 
then washed 5 times with 1 ml im­
munoprecipitation buffer (50 mM Tris/H­
Ac, pH 8.0, 0.5 M NaCl, 0.1% NP-40) 
and stored at 4°C. Before im­
munoprecipitation the protein samples, 
containing 10 μg of biotinylated protein, 
were clarified by centrifugation (20 min., 
15,000 g, 4°C). The supematants were 
incubated with 20 μί of the antibody-
loaded protein A Sepharose beads, in the 
presence of protease inhibitors, in 1 ml of 
immunoprecipitation buffer, during 2 h at 
4°C, in an end-over-end rotator. The 
protein A Sepharose beads were centri-
fuged and washed 3 times with im­
munoprecipitation buffer. The pellet was 
dissolved in 20 μί SDS-PAGE loading 
buffer and a 10 μί sample was resolved by 
SDS-PAGE [37] for subsequent strep-
tavidin analysis. 
Elastase inhibition assay 
The activity of porcine pancreas elastase 
(Whatman) was monitored spectrophoto-
metrically at 405 nm using the substrate 
N-methoxysuccinyl-L-alanyl-L-alanyl-L-
prolyl-L-valine-p-nitroanilide (Sigma). The 
assay mixture contained 2 μg elastase and 
1.0 mM substrate in a 10 mM Tris buffer 
(pH 8.0). Inhibition was assessed after 
preincubation of elastase with inhibitor for 
3 minutes, at room temperature, and initia­
ting the reaction by the addition of sub­
strate. 
Heat protection assay 
The capacity of HSP25 and the o-crystal-
lin subunits to protect flL-crystallin and 
yeast or-glucosidase (Sigma Chemical Co.) 
against heat-induced aggregation was 
performed as follows: The apparent ab­
sorption at 360 nm, due to scattering, was 
measured in a Beekman DU 70 spectro­
photometer, equipped with a 6-cell-holder 
accessory, and a Peltier temperature con­
troller accessory. The temperature of the 
samples in the cells was measured by 
inserting a small bead-thermocouple inside 
one of the 6 cells in the holder. Teflon-
stoppered, black-walled, 10 mm-path-
length, 2 mm wide cells were used. In 
each experiment the total volume in the 
cell was 400 μί. The scattering of each 
cell was sampled and recorded automati­
cally every 20 sec. Proteins and buffers 
were mixed in the cell at room tempera­
ture. The average time required for the 
mixture inside the cell to reach the prede­
termined temperature of the cell holder 
was approximately 5 min. 
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Determination of transglutaminase 
substrates 
To study the lysine-substrate capacity in 
the transglutaminase-mediated crosslink-
ing, punned α-crystallin and HSP2S were 
treated with guinea-pig liver transglutami­
nase (Sigma), in the presence of a biotiny-
lated amine-acceptor hexapeptide, and 
analysed essentially as described by Groe­
nen et al. [30]. 
Miscellaneous methods 
Digestion of α-crystallin and recombinant 
HSP2S with carboxypeptidase В (Merck) 
was performed as described by Siezen et 
al. [38]. Alkaline urea gel electrophoresis 
was carried out at pH 8.S [32]. Im-
munoblot analysis was performed accor­
ding to Mulders et al. [39]. For Western 
blotting, the polyclonal antisera against 
aA-, aB-crystaUin and recombinant 
HSP2S (the latter obtained from A. Zan-
tema [40]) were used at a 1:2000 dilution. 
The peroxidase-conjugated swine anti-
rabbit immunoglobulins (SwaRPO, Dako-
patts) were used at a 1:200 dilution. Strep-
tavidin blot analysis was carried out as 
described by Groenen et al. [30]. 
RESULTS 
Secondary structure of a-crystaUin and 
HSP25 
Although the tertiary structure of α-crys­
tallin is not yet known, secondary struc­
ture data are available. Circular dichroism 
experiments have revealed that α-crystal­
lin has mainly β-pleated sheet confor­
mation and contains very little α-helix 
conformation [41, 42]. To compare the 
secondary structures of α-crystallin and the 
small HSP2S, far UV CD measurements 
were performed on α-crystallin isolated 
from calf cortex, recombinant aA-crystal-
lin and recombinant HSP2S. These spectra 
are shown in Fig. 1. The profile of all 
three spectra is very similar, with a single 
minimum at —217 run. These spectra are 
typical of predominantly β-sheet proteins 
[43]. The intensity differences among the 
three profiles are most probably due to 
differences in protein concentrations. 
These results suggest that the secondary 
structure of recombinant aA and the re­
combinant HSP25 are very similar to that 
of the native a-crystaUin. 
Stability of oA-crystallin, aB-crystallin 
and HSP25 aggregates 
The quaternary structure of α-crystallin 
and its urea stability have been studied 
extensively [e.g. 42, 44]. The smaU HSPs 
and α-crystallin form similar aggregates, 
with respect to size [19-21, 28] and par­
ticle shape [23-27, 45]. To obtain an 
additional indication that a-crystaUins and 
HSP2S have similar structural properties, 
their stability was studied by measuring 
CD [mdeg] 
10.0 
7.5 
5.0 
2.5 
0.0 
-2.5 
-5.0 
-7.6 
-10.0 
- t t 
195 205 215 225 235 245 
Wavelength [nm] 
Fig. 1: Far UV circular dkhroism spectra of «-
crystallin and HSP25. Curve 1; calf lens a-crys­
taUin, protein concentration —0,7 mg/ml, path-
length 0.25 mm. Curve 2; recombinant HSP2S, 
protein concentration —0,7 mg/nd, pathlength 0.2S 
nun. Curve 3; recombinant aA-cryetallin, protein 
concentration -0,35 mg/ml, pathlength 0.5 mm. 
Each spectrum is the average of 8 scans. 
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the tryptophan fluorescence wavelength 
maxima as a function of urea concentra­
tion. Since inconsistent results were ob­
tained earlier for the transition points of 
oB-crystallin [42, 44], most probably due 
to the use of buffers with different pH, the 
measurements in this study were carried 
out at three different pH values. Two 
distinct isolates for each polypeptide were 
used to measure urea transition curves. 
Because the transition points at pH 7.0 of 
aA-crystallin, aB-crystallin and HSP25 
are 2.54, 2.53 and 2.52 M urea, respec­
tively (Fig. 2A) it may be concluded that 
all three proteins are equally stable. The 
shape of the aA-crystallin transition curve 
is somewhat flatter than those of aB-crys­
tallin and HSP25, but still has the same 
transition point. At lower pH the stability 
of aB-crystallin decreases significantly. 
The transition point at pH 6.0 drops to 
1.54 M (Fig. 2B). The stability of aA-
Хтш [um] pH 7.0 
мгах [nm] 
[Ure·] [M] 
Fig. 2: Urca dcnaturation curres of αΑ-crystal-
lin(O), oB-crystallm (O) and HSP25 (x ) . 
Tryptophan fluorescence emission inanima were 
measured te • function of urea coocentnUon in SO 
mM Bistris at pH 7.0 (A) and pH 6.0 (B). The 
transition points were determined as described in 
Materials and Methods. 
crystallin is not decreased at lower pH, 
whereas the stability of HSP25 is slightly, 
but not significantly, reduced at lower pH. 
Apparently, the earlier observed discrepan­
cy between the measured stabilities of aB-
crystallin [42, 44] is due to the different 
pH values used in these two studies. 
Formation of mixed aggregates 
Recently, Kato et al. [46] reported the 
copurification of aB-crystallin and the 
human small HSP from pectoral muscle. 
Zantema et al. [40] were able to immuno-
precipitate both aB-crystallin and the 
mouse small HSP from non-oncogenic 
adenovirus-transformed cell lysates, using 
antibodies directed against either of the 
two proteins. These results strongly sug­
gest the in vivo occurrence of aB-crystallin 
and small HSPs in the same aggregate. 
The questions arise whether mixed ag­
gregates of aB-crystallin and HSP25 can 
Ve 
_1 
•70 440 290 kDa 
6 = 4 - 4 = 
» · 
ρΗβ.Ο 
AleluA 
Alphas 
H3PÎ5 
AlphaA · HSP2S 
Alphas · HSP25 
30 за 40 
Elution tuna (min) 
Fig. 3: Gd permeation analysis of aA-crystallin, 
aB-crystallin and HSP25, and of aA/HSP25 and 
aB/HSnS mixtures. Superóse 6B chromatography 
patterns of the indicated polypeptides and polypep-
tide mixtures, after dcnaturation and «aggregation. 
SDS-PAGE patterns of gel filtration fractions of the 
polypeptide mixtures are displayed directly under 
the corresponding edition profiles, the upper band 
represents HSP25, whereas the lower band repre-
sents aA or aB; Unes correspond with the fractions 
directly above them m the elution pattern. The void 
volume (VJ and the position of gel filtration 
markers are indicated. High molecular weight 
aggregates, during at V„, were sometimes ob-
served. 
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Flg. 4: Streptavidin blot of immunoprecipitated 
fractions of biotinylated aA-crystallin, eB-
cryslallin and HSP25, and of oA/HSF25 and 
aB/HSP25 mixed aggregates. Biotinylated 
OA/HSP25 (lane 1) and aB/HSP25 (lane 2) mixed 
aggregates were immimopiecipitaled with anti-aA 
Oane 10) and anti-HSP25 (lane 11), or anti-aB 
(lane 12) and anti-HSP25 (lane 13), respectively. 
Controls are aA-crystallin, immunoprecipiuted 
with anti-aA (lane 3) and anti-HSP2S (lane 4); 
aB-crystallin, immunoprecipitated with anti-aB 
(Une 5) and anti-HSP25 (lane i); and HSP2S, 
immunoprecipitated with anti-HSP2S (lane 7), 
anti-aA (lane 8) and anti-aB (lane 9). To demon­
strate the selectivity of the aggregate formation, the 
water-soluble fraction of an HSP25-expiessing 
E.coli strain was mixed with aB-crystallin (lane 14) 
and immunoprecipitated with anti-HSP2S (lane IS). 
The extra band in lane 7 represents a degradation 
product of HSP2S. 
also be assembled in vitro, and whether 
aA-crystallin/HSP25 mixed aggregates can 
be formed too. 
To that end HSP2S was mixed with either 
orA- or aB-crystallin under denaturing 
conditions and reaggregated by dialysis 
against water. As a control, the pure poly­
peptides (aA, otB and HSP25) were sub­
jected to the same reaggregation proce­
dure. Dissociation of α-crystallin ag­
gregates is known to be reversible [42, 47, 
48] and the applied aggregation procedure 
has been shown to yield normal a-crystal-
lin aggregates [e.g. 42]. The reaggregated 
polypeptides and their mixtures were 
analysed by gel permeation chromatogra­
phy, at least in duplicate, resulting in 
elution volumes with variations less than 
2%. From Fig. 3 it can be concluded that 
in all cases large aggregates are formed, 
although some minor differences in the 
elution volumes are observed. However, 
the elution volumes of aA-crystallin 
(12.28 ml) and the aA/HSP25 mixture 
(12.24 ml) correspond very well. The 
same is true for aB-crystallin (12.54 ml) 
and the aB/HSP25 mixture (12.52 ml). In 
the insets in Fig. 3 the SDS-PAGE com­
positions of the fractions corresponding 
with the peak of the elution pattern of the 
two mixtures are shown. Clearly, the 
polypeptides present in a mixture are 
coeluting. 
It might well be that the proteins present 
in a mixture form separate homopolymers, 
that elute at the same volume. To rule out 
this possibility, an immunoprecipitation 
experiment was carried out. Biotinylation 
of the reaggregated polypeptides and their 
mixtures was performed to facilitate the 
detection of immunoprecipitated proteins 
by subsequent streptavidin blot analysis. 
The biotinylated polypeptide mixtures were 
treated with antisera, directed against only 
one of the two components of the mix­
tures, as described in Materials and 
Methods. The mixtures and their im-
munoprecipitation pellets were analysed by 
SDS-PAGE and streptavidin blot analysis 
(Fig 4). From lanes 10-13 it can be con­
cluded that both components present in a 
mixture (aA and HSP25, or aB and 
HSP25) are precipitated by an antiserum 
specific for only one of the components. 
Since aA- and aB-crystallin show se­
quence homology with the small HSPs, it 
cannot a priori be excluded that the an­
tisera raised against these polypeptides 
would cross-react. Therefore, controls for 
possible cross-reactivity were carried out 
(Fig. 4, lanes 3-9). In none of the cases an 
antiserum was able to precipitate the other 
polypeptide. Only in lane 6, where aB-
crystallin was incubated with anti-HSP25 
agarose beads, a very weak aB-crystallin 
band was observed. However, this weak 
signal cannot explain the strong signal 
obtained in lane 13. Therefore, it is more 
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likely that the weak band in lane 6 is 
caused by insufficient washing of the 
immune-precipitation pellet. By comparing 
lanes 10 and 12 with lanes 11 and 13, 
respectively, it can be seen that the anti-
HSP2S antibody precipitates relatively 
more HSP2S from the mixed aggregates 
than do the anti-αΑ or anti-aB antibodies. 
This implies that not all HSP2S subunits 
are necessarily present within the mixed 
aggregates. To demonstrate the selectivity 
of the aggregate formation between a-
crystallin and HSP2S, the water-soluble 
fraction of an HSP2S-expressing E.coli 
strain, in which most bacterial proteins are 
present, was mixed with aB-crystallin and 
treated like the other protein mixtures. 
From all proteins present, only orB and 
HSP2S were immunoprecipitated with the 
anti-HSP25 antiserum (Fig. 4, lanes 14, 
IS). These experiments demonstrate that 
mixed aggregates of aA/HSP25 and 
aB/HSP25 can be formed in vitro. This 
strongly suggests that the subunit positions 
in the quaternary structure can be equally 
well occupied by oA, aB or HSP25. 
Inhibition of thermal aggregation of 
/3-crystalIin by o-crystallin and HSP25 
Recently, it has been shown that a-crystal-
lin and its isolated subunits function as 
molecular chaperones, protecting proteins 
against heat-induced aggregation [31]. 
Since a molecular chaperone-like function 
would be attractive for the small HSPs 
too, we repeated the experiment with the 
mouse HSP2S. To this end, a solution of 
BL-crystallin was heated to 58°C in the 
absence or presence of HSP2S or a-crys-
tallin. Apparently, the heat-induced ag­
gregation of BL-crystallin (Fig. 5, curve 1) 
is suppressed by HSP2S and a-crystallin 
(Fig. S, curves 3 and 4). Assuming the 
average native molecular weight of £L to 
be -60,000 and for HSP2S to be around 
600,000, a molar ratio of about 40:1 of BL 
to HSP2S produces a significant effect in 
delaying the aggregation process and in 
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Fig. 5: Aggregation of BL-crystallin at 58"C in 
the absence and presence of HSP25 or a-crystal­
lin. In each experiment 0.13 mg 6L in SO mM 
sodium phosphite, pH 7, was used. Aggregation of 
BL was measured, either alone (curve 1), or in the 
presence of 0.034 mg HSP25 (curve 2), 0.067 mg 
HSP25 (curve 3) or 0.07S mg o-crystallin (curve 
4). The final volume in each experiment was 0.4 
ml. 
lowering the rate of aggregate formation 
(Fig. 5, curve 2). With a molar ratio of 
20:1 of BL to HSP2S, aggregation is al­
most completely suppressed (Fig. 5, curve 
3). Additionally, the HSP25-induced heat-
protection of yeast o-glucosidase at 49°C 
was tested. Similar results were obtained, 
with a molar ratio of 10:1 of a-glucosidase 
to HSP25, resulting in complete sup­
pression of aggregation (results not 
shown). 
ot-Crystallin and HSP25 as substrates 
for transglutaminase. 
Tissue transglutaminase catalyses the 
formation of c-(7-glutamyl)-lysine isopep-
tide crosslinks between polypeptides, and 
the conjugation of amines to protein-bound 
glutamines [49, 50]. It has been shown 
[30] that αΒ-crystallin, but not aA-crystal-
lin, can serve as an amine-donor substrate 
in the transglutaminase-mediated crosslink-
ing. Bovine aB-crystallin differs from aA-
crystallin in having two lysine residues at 
its C-terminus [SI]. It is indeed the C-ter-
minal lysine of aB-crystallin that has been 
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Flg. í : Lysine-substrate capacity of α-crystallin and HSF25 in the transglutaminase mediated 
crosslinking. (A) Alkaline urea gel electrophoresis pattern of mouse HSP2S (1 pg, lanes 1 and 2) and 
bovine a-crystallin (20 μg, lanes 3 and 4) before (lanes 1 and 3) and after (lanes 2 and 4) carboxypeptidase 
В digestion. The distance between intact and truncated HSP2S (arrow) is approximately equal to the distance 
between intact and truncated aB-crystallin, demonstrating the loss of a single positive charge, due to the 
removal of the C-tenninal lysine residue [30]. Carboxypepbdase В does not affect αΑ-crystallin. (B,C) SDS 
gel electropboretìc pattern after CBB-staining (B) or streptavidin blotting (C) of mouse HSP2S (lanes 1 and 
2) and calf α-crystallin (lanes 3 and 4) before (lanes 1 and 3) and after (lanes 2 and 4) digestion with 
carboxvpeptidase B. Note that the loss of a single lysine residue in aB-crystallin, but less so in HSPZ5, 
leads to a detectable higher mobility in SDS-PAGE. All samples have been incubated with Ca2*-activated 
transglutaminase and the amine-acceptor probe. Comparison of the CBB pattern (B) and the corresponding 
streptavidin blot (C) shows that aB-crystallin and HSP2S, but not aA-crystallin, are amine-donor substrates. 
Carboxypeptidase В digestion results in loss of the amine-donor capacity. Molecular masses of the marken 
in lane M are indicated in kDa. 
identified as the amine-donor residue. 
Since also the mouse HSP2S contains a 
C-terminal lysine [33], the question arises 
whether this lysine residue can serve as an 
amine-donor as well. To address this 
question the purified recombinant mouse 
HSP2S and, as a control, α-crystallin were 
incubated with transglutaminase, Ca 2 + and 
the biotinylated amine-acceptor probe, and 
analysed as described in Materials and 
Methods. Obviously, HSP2S can be 
decorated, like aB-crystallin, with the 
biotinylated hexapeptide (Fig. 6B,C, lanes 
1 and 3), whereas αΑ-crystallin is not 
decorated (Fig. 6B,C, lane 3). This de­
monstrates that HSP25 can serve as amine-
donor substrate. To identify the amine-
donor residue, HSP2S and α-crystallin 
were treated with carboxypeptidase B, to 
remove the C-terminal lysine residue. The 
loss of a single positive charge, and thus 
the effectiveness of the digestion, is clearly 
demonstrated by alkaline urea gel electro­
phoresis (Fig. 6A). Subsequent reaction 
with the amine-acceptor probe, and analy­
sis by SDS-PAGE and streptavidin blot 
shows that both HSP25 and aB-crystallin 
no longer react with the probe upon remo­
val of the C-terminal lysine (Fig. 6B,C, 
lanes 2 and 4). This convincingly demon­
strates that the C-terminal lysine in 
HSP2S, as in aB-crystallin, serves as the 
amine-donor residue. 
Inhibition of elastase 
It has been shown that α-crystallins are 
efficient inhibitors of elastase [29]. It 
appears that α-crystallin inhibits elastase 
for 90% at stoichiometric levels, based on 
800 kDa aggregates. We investigated 
whether also HSP2S abolishes the hydroly­
sis by elastase of a synthetic substrate as 
described in Materials and Methods. Fig. 
7 demonstrates that indeed HSP2S inhibits 
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Rg. 7: Elastase inhibition curres of HSF25, 
α-crystallin and controls. ElasUse activity was 
measured spectrophotometricaUy (Materials and 
Methods) after incubation with increasing amounts 
of HSP2S ( · ) , o-crystallin (O), γ-crystallin (ж) 
and BH-crystallin (•). Data are presented as 
percentage of the activity of elastase alone. 
elastase, although somewhat less pronoun­
ced than a-crystallin. To confirm that 
elastase inhibition by a-crystallin and 
HSP2S is specific, other bovine crystalline 
were tested, as well as bovine serum 
albumin, for their ability to inhibit elas­
tase. In Fig. 7 the inhibition curves are 
included for 7- and BH-crystallin, showing 
that these crystallins do not influence 
elastase activity. The same results were 
obtained for BL-crystallin and bovine 
serum albumin, using up to 100 μg of 
these proteins (data not shown). Obvious­
ly, α-crystallin and HSP2S are efficient 
and specific inhibitors of elastase under the 
conditions used in this assay. 
DISCUSSION 
Among the ubiquitous family of small heat 
shock proteins, the α-crystallins are most 
closely related with the mammalian and 
avian 24-28 kDa HSPs [3]. The sequence 
homology between α-crystallins and the 
mammalian small HSPs [52, S3], the 
resemblance of their hydropathy profiles 
[S3, 54], their similar aggregate size and 
electron microscopic appearance [19-27], 
all make it likely that they have the same 
conformations. a-Crystallin and small HSP 
subunits are likely to have a compact two-
domain structure, with a short extending 
C-terminal arm [55]. Unfortunately, how­
ever, direct information about the spatial 
conformation of both α-crystallins and 
small HSPs is very limited. Having thus 
far resisted crystallization, no X-ray dif­
fraction studies are available for these 
proteins. Similarly, the quaternary struc­
ture of α-crystallin is a matter of vigorous 
debate. Arguments have been presented for 
a three-layered spherical model [56, 57] 
and for a micellar structure [58], as well 
as for a combination of both [59]. For 
mouse HSP25 a sphere-like structure 
composed of about 32 monomers, arranged 
in hexagonal packing, has been proposed 
[45]. Direct measurements for secondary 
structure elements have only been pu­
blished for α-crystallins, revealing prima­
rily β-sheet conformation and very little 
α-helical structure [41, 42, 47]. 
One of the aims of the present work is to 
provide additional evidence for the simila­
rity of the secondary and quaternary struc­
tures of α-crystallin and small HSPs. The 
far UV CD spectra of bovine a-crystallin 
and mouse HSP2S clearly demonstrate that 
the secondary structure of HSP25 resem­
bles very much that of α-crystallin, both 
consisting of mainly β-pleated sheets. This 
finding supports the assumption that a-
crystallin and HSP25 have similar confor­
mations. 
To provide evidence for similar structural 
stability of aA-crystallin, aB-crystallin and 
HSP2S, the dissociation of the aggregates 
in urea was assessed by tryptophan fluo­
rescence measurements. Normally, tryp­
tophan fluorescence measurements are 
used to monitor tertiary structure trans-
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irions, i.e. unfolding. For a-crystallin, 
however, it has been shown that the trans­
ition of fluorescence maxima occurring at 
2.S M is rather the result of a quaternary 
structure transition, i.e. dissociation [42, 
44]. Therefore, we further consider the 
observed transitions for the a-crystallin 
subunits and HSP25 the result of dis­
sociation. At pH 7.0 all three denaturation 
curves have equal transition points 
(2.5-2.6 M urea). At lower pH, aA-crys-
tallin and HSP25 homopolymers remain 
equally stable, whereas the stability of orB-
crystallin decreases significantly (1.5 M at 
pH 6.0). This seems in agreement with the 
observation of Augusteyn et al. [60] that 
аВ-crystallin specifically dissociates from 
the a-crystallin aggregate at low pH. 
Apparently, this is due to destabilization of 
the quaternary structure interactions of oB-
crystallin at lower pH. The fact that, at pH 
7.0, all three proteins are equally stable, 
suggests that under physiological con­
ditions similar interactions are playing a 
role in the aggregate formation of the three 
homopolymers. Also the fact that mixed 
aggregates can be formed from any com­
bination of the αΑ-crystallin, аВ-crystallin 
and HSP25 subunits implies that similar 
quaternary structures, with equivalent 
subunit positions in the aggregates, are 
formed. 
Like their structural properties, the actual 
biological functions of both the small 
HSPs and α-crystallins are still largely 
unknown. In the lens, a-crystallin is as­
sumed to have a structural role because of 
its very abundance [61]. However, the 
original function of аВ-crystallin, and 
probably of αΑ-crystallin as well, must be 
looked for outside the lens. It is becoming 
increasingly clear that аВ-crystallin and 
the small HSPs share important properties 
that are relevant for their common funct­
ioning as stress proteins (reviewed in [3]). 
These include stress-inducibility [9-11] and 
intracellular relocalization upon stress [9, 
16, 18]. Both proteins appear to be in­
volved in major cytomorphological reor­
ganizations, both during normal develop­
ment and under pathological conditions 
[13-16, 62-66]. Common features of a-
crystallins and small HSPs are also their 
interactions with plasma membranes 
[67-70] and cytoskeletal elements [71-74], 
and the fact that they can be phosphory-
lated [34, 75-77]. To strengthen the notion 
that a-crystallin and the small HSPs in­
deed have common functions, we inves­
tigated whether calf a-crystallin and mouse 
HSP25 share some more properties. It has 
recently been found that aA- as well as 
аВ-crystallin can act in several aspects like 
molecular chaperones [31]. a-Crystallin is 
able to prevent proteins from heat-denatu-
ration and is helpful in refolding chemical­
ly denatured 7-crystallin. In this work we 
demonstrate that the mouse small HSP is 
able, like a-crystallin, to prevent heat-
induced aggregation of /SL-crystallin and 
of yeast α-glucosidase at substoichiometric 
levels. Comparable proof for the chape-
rone-like properties of HSP25 and a-crys­
tallin has independently been obtained by 
Jakob et al. [78]. It is very likely that the 
stabilizing capacity of these proteins is of 
significance also in vivo, preventing un­
desirable protein interactions during pe­
riods of stress. 
While the chaperone-like role is most 
probably the most prominent feature of 
α-crystallin and small HSPs, there are 
some other properties of potential funct­
ional importance that might be shared 
between these proteins. Recently, it has 
been shown that the C-terminal lysine of 
аВ-crystallin is an amine-donor substrate 
in the transglutaminase-mediated crosslink-
ing reaction of proteins [30]. We now 
demonstrate that HSP25 has the same 
substrate capacity and that, like in аВ-
crystallin, the C-terminal lysine is the 
amine-donor residue. This indicates that 
transglutaminase does not have very strict 
amine-donor substrate requirements, the 
C-terminal sequences of аВ-crystallin and 
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HSP25 being -Ala-Val-Thr-Ala-Ala-Pro-
Lys-Lys-OH and -Lys-Ser-Glu-Gln-Ser-
Gly-Ala-Lys-OH, respectively [33, 51]. 
Our findings confirm in an indirect manner 
that the C-terminal lysines of aB-crystallin 
and HSP25, being accessible for transglu­
taminase, are located in extending arms. It 
is unclear what implications the substrate 
capacity for transglutaminase may have for 
aB-crystallin and HSP2S under normal 
conditions. It has been proposed that trans­
glutaminase activity is implicated in con­
trolled cell death [79], tumor progression 
[80], stimulated secretion [81], and recep­
tor-mediated endocytosis [82]. These are 
processes which involve changes in the 
intracellular organization. The fact that 
aB-crystallin and small HSPs are also 
implicated in cytomorphological changes 
may provide a clue for the interactions 
between these proteins and transglutami­
nase. 
α-Crystallin is known to inhibit elastase 
activity [29]. This property may be of 
functional importance in the lens. Because 
there is no protein turnover in the lens, the 
prevention of untimely degradation of lens 
proteins by endogenous proteases is of 
great importance. A similar protease in­
hibiting capacity might be useful for small 
HSPs as well, to avoid the proteolysis of 
transiently unfolded proteins during stress. 
By incubating elastase with increasing 
amounts of HSP2S, we could demonstrate 
that also HSP2S is able to inhibit elastase 
activity, albeit somewhat less efficiently 
than α-crystallin. This may be due to 
improper folding of HSP2S, or to differen­
ces in aggregate size. It should be noted 
that the elastase inhibition experiments are 
carried out in a low ionic strength buffer, 
not corresponding with the actual con­
ditions in lens or other tissues. Under 
conditions with higher ionic strength, a-
crystallin is not able to inhibit elastase 
(results not shown). However, elastase is 
most probably not the actual serine pro­
tease that is inhibited in vivo by a-crystal-
lin and HSP2S. Other, yet unknown prote­
ases might be efficiently inhibited under 
more physiological conditions. 
The original biological role of both aA-
and aB-crystallin is most probably, like 
for the small HSPs, to function as stress 
proteins in tissues outside the lens. Their 
thermostability [83] and chaperone proper­
ties make it understandable that the consti-
tutively high expression of α-crystallin in 
the eye lens is an evolutionarily useful 
feature for maintaining lens transparency. 
They thus resemble the enzyme/crystallins, 
like lactate dehydrogenase В and a-eno-
lase, which also have been recruited unal­
tered to function as abundant structural 
proteins in the lenses of certain vertebrates 
[58]. 
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CHAPTER 3 
Expression and aggregation of recombinant aA-crystallin 
and its two domains 

Expression and aggregation of recombinant aA-crystallin 
and its two domains. 
The 20-kDa oA and aB subunits of α-crystalhn from mammalian eye loues form large aggregates with in 
average molecular weight of 800,000. To get insight mio the interactions responsible for aggregate 
formation, we expressed ш E.coti me putative N- and C-tenninal domains of агА-ciystallin, as well as the 
intact aA-crystalLm chain. The proteins are expressed m a stable form and in relatively high amounts 
(20-60% of total protein). Recombinant aA-crystallin and the C-tenmnal domain are expressed m a water-
soluble form. Recombinant aA-crystallin forms aggregates comparable with α-crystalhn aggregates from 
calf lenses, whereas the C-tenmnal domain forms duneis or tetramere. The N-tenninal domain is expressed 
ш an initially water-insoluble form. After solubilization, denaturation and ^aggregation the N-terminal 
domain exists m a high-molecular weight multimene form. These observations suggest that the interactions 
leading to aggregation of aA-crystallin subumts are mainly located in the N-terminal half of the chain. 
INTRODUCTION 
Until recently a-crystallin was known as a 
typical organ-specific structural protein of 
the vertebrate eye lens [for reviews see 
1-3]. It is normally isolated in the form of 
large water-soluble aggregates (500-900 
kDa), composed of two types of homolo­
gous subumts, orA and aB. The a-crystal-
lins are structurally related with the ubi­
quitous small heat shock proteins (HSPs)1 
[4-6]. It has recently been established that 
both subunits also occur outside the lens 
[7-9]. The properties of aB in non-lens 
cells resemble those of the small HSPs 
[10]. 
Unfortunately, very little is known about 
the three-dimensional structure of both 
α-crystalhn and the small HSPs. This se­
riously hampers the understanding of the 
biological functioning of these proteins. 
Like a-crystallin, the small HSPs form 
large aggregates (200-800 kDa) [11-14], 
and both proteins appear in the electron 
microscope as 10-17 nm globular, some­
times torus-like or hollow-core particles 
[12, 15-18]. The quaternary structure of a-
crystallin is a matter of debate; although a 
three-layered structure seems to be the 
most favoured [19,20], a micelle-like 
model has also been propagated [21]. 
It has been proposed that the subunits of 
a-crystallin and small HSPs are composed 
of two similarly folded domains and a C-
terminal tail [22]. A two-domain structure 
is supported by folding/unfolding studies 
of α-crystallin subunits [23]. Because the 
sequence homology between a-crystallins 
and the small HSPs is most pronounced in 
the C-terminal domains, it was suggested 
that the common tendency to aggregate 
derives from this part of the protein [4]. 
On the other hand, the N-terminal domain 
of the α-crystallin subunits is definitely 
more hydrophobic than the C-terminal 
domain. This makes it more likely that the 
' The abbreviations used are: HSP, beat shock protein; aA2D, residues 64-173 of rat aA-crystallin; 
oAlD, residues 1-63 of calf αΑ-crystallin; WSF, water-soluble fraction; USF, urea-soluble fraction; 
UIF, urea-insoluble fraction; SDS, sodium dodecyl sulfate, PAA, Polyacrylamide; PAGE, Polyacryl­
amide gel electrophoresis; LMW, low molecular weight; HMW, high molecular weight; IPTG, 
isopropylthio-B-D-galactoside; PMSC, phenylmethylsulfonyl chloride; CBB, Coomassie Brilliant Blue; 
bp, base pair; ds, double-stranded. 
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N-terminal parts of the polypeptides are 
largely responsible for the aggregation 
behaviour, and has indeed led to the mi­
celle-hypothesis for a-ciystallin aggregates 
[21]. To distinguish between these oppo­
sing views, and to demonstrate that ot-crys-
tallin subunits are indeed composed of two 
independently folded domains, we decided 
to produce the putative domains of aA-
crystallin by recombinant-DNA methods, 
and study their properties. 
MATERIALS AND METHODS 
Bacterial strains, plasmids and reagents 
E.coli strains HMS174 [24] and JM105 
[25] were used as recipients in the cloning 
experiments. For overproduction of recom­
binant proteins either E.coli strain В 
BL21(DE3) or В BL21(DE3).pLysS was 
used. Plasmids used in the cloning ex­
periments were рЕТЗЬ and pET8c [24]. 
Ampicillin, chloramphenicol, IPTG, chi­
cken egg white lysozyme, DNAase I and 
protease inhibitors were obtained from 
Sigma. Restriction enzymes, T4 DNA 
polymerase, T4 DNA ligase and T4 poly­
nucleotide kinase were purchased from 
Bethesda Research Laboratories (BRL). 
The crosslinking agent dimethyl suberimi-
date was obtained from Pierce Chemical 
Co. TPCK-treated trypsin was purchased 
from Worthington Biochemical Cor­
poration. Oligonucleotides were synthe­
sized using a Cyclone Plus DNA synthe­
sizer from Milligen/Biosearch. 
Plasmid constructions 
The partial cDNA clone pRLaA-1 as 
described by Moormann et al. [26] was 
used to make the expression construct 
pET3boA2D, expressing residues 64-173 
of rat αΑ-crystallin (oA2D, Fig. 1С). The 
clone pBLaA-1 [27], containing the entire 
coding sequence of bovine αΑ-crystallin 
was used to make the expression con­
structs pET8caA and pET8caAlD, en­
coding bovine aA-crystallin (173 resi­
dues) and residues 1-63 of bovine αΑ-
crystallin (otAlD), respectively (Fig. 
1 A,B). The pET expression system of 
Studier et al. [24] was used to make all 
the expression constructs. Sequences co­
ding for the above mentioned proteins 
were ligated in the different expression 
plasmids with the help of adaptors, as 
described in the legend of Fig. 1. All 
adaptors were unphosphorylated and were 
ligated using the procedure described by 
Haymerle et al. [28]. The ligation mix­
tures were used to transform E.coli 
HMS174 or JM10S and the desired ex­
pression constructs were isolated according 
to Sambrook et al. [29]. 
Expression and purification 
For expression, the constructs pETScaA 
and pET8caAlD were transformed in the 
host E.coli BL21(DE3), while the con­
struct pET3baA2D was transformed in the 
same host, containing the plasmid pLysS, 
to facilitate cell lysis. Induction was per­
formed by making the culture 0.5 mM in 
IPTG when the culture reached an OD600 
of 0.6-1. Three hours after induction, cells 
from a 450 ml culture were harvested, 
resuspended in 20 ml of TEN-buffer 
(50 mM Tris (pH 7.5), 0.3 M NaCl, 
0.5 mM EDTA, 0.02 μΜ PMSC), con­
taining 1/1000 volume of protease in­
hibitor stock solution (2 mg/ml pepstatin, 
0.1 M benzamidin-HCl, 1 mg/ml anti-
pain, 1 mg/ml bacitracin, 5 mg/ml soy­
bean trypsin inhibitor, 2 mg/ml aproti-
nin), like all other solutions used in this 
procedure, and lysed either by incubation 
with 1 mg/ml chicken egg white lysozyme 
during 30 min on ice or by freeze-thawing 
(pLysS strain). DNA was degraded by 
DNAase I (2 /ig/ml) on ice, during 1 hr. 
By centrifugation (30 min at 15,000xg) the 
suspension was divided into a water-
soluble fraction (WSF) and a pellet. The 
washed pellet was resuspended in 25 ml of 
cracking buffer (0.01 M sodium phos-
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phate, pH 7.2, 1% of ß-mercaptoelhanol, 
6 M urea, 0.02 μΜ PMSC). The urea-
soluble fraction (USF) was obtained by 
centrifugation (45 min at lS.OOOxg). The 
pellet was washed with 25 ml of cracking 
buffer and centrifuged again and the urea-
insoluble fraction (UIF) was obtained. 
Proportional amounts of each fraction were 
loaded either on an SDS-polyacrylamide 
gel [30] or a Tiicine-SDS-polyacrylamide 
gel [31]. aA2D was punned from 
pET3borA2D WSF by antibody affinity 
chromatography. An affinity column, 
specifically retaining the C-terminal se­
quence of aA-crystallin was made by 
binding 1 ml ascites fluid of the mono­
clonal antiserum Cr.I-1 [32] to 1.75 ml of 
cyanogen bromide activated Sepharose 4B 
(Pharmacia) according to Stevens and 
Augusteyn [33]. The affinity column was 
loaded with up to 15 mg of protein, de­
rived from the WSF of pET3baA2D. 
Proteins bound through non-specific inter­
actions were then eluted with 0.1 M gly-
cine-HCl (pH 5.0). Specifically bound 
protein was eluted with 0.1 M glycine-
HC1 (pH 2.5). Fractions containing oA2D 
were collected, dialysed against water and 
lyophilized. 
Characterization 
The apparent molecular weight of the 
expressed proteins was estimated by SDS-
PAGE, while the immunochemical identity 
was established by Western blotting. A 
polyclonal antiserum raised against calf 
aA-crystallin was used to identify recom­
binant aA-crystallin. To identify aA2D, 
the monoclonal antiserum Cr.I-1 [32], 
reacting with C-terminal sequences of rat 
aA-crystallin, was used. For identification 
of aAlD, a polyclonal antiserum, directed 
against a synthetic peptide containing 
residues 49-63 of bovine aA-crystallin, 
was used [34]. 
Expressed proteins were further identified 
by analysis of their tryptic peptides. Tryp-
tic digestion was performed on the WSF of 
recombinant αΑ-crystallin, containing up 
to 80% of the expressed protein. To obtain 
pure aA2D, the band containing aA2D 
was cut out from a SDS-polyacrylamide 
gel and isotachophoresed according to 
Öfverstedt et al. [35]. To obtain tryptic 
peptides of aAlD, the crude USF of 
aAlD was used. Tryptic peptides of the 
expressed proteins were separated either 
by high voltage paper electrophoresis at 
pH 6.5 and descending chromatography 
[36] or reversed phase HPLC on a RP-18 
column (Merck) [37] and analysed, after 
hydrolysis, on a LKB-Alpha Plus amino 
acid analyser. 
Aggregation 
Aggregate sizes of recombinant proteins 
were estimated by means of FPLC gel 
permeation chromatography, using a Supe-
rase 6 HR 10/30 prepacked column (Phar-
macia-LKB). The column was equilibrated 
with 50 mM phosphate (pH 7.5), 50 mM 
NaCl and 1 mM EDTA. The column was 
eluted at room temperature, at a flow rate 
of 0.5 ml/min and monitored by absor-
bance at 280 nm. Low and high molecular 
weight markers from the Pharmacia gel 
filtration calibration kit were used to es-
timate the molecular mass of the ag-
gregates. 
Samples (1 mg of protein) of the water-
soluble fraction of bacteria expressing 
αΑ-crystallin or aA2D were directly 
applied to the gel filtration column. Ad­
ditionally, affinity-purified aA2D was 
dissociated by 6 M urea in FPLC elution 
buffer, and reaggregated by dialysis 
against this phosphate buffer, the protein 
concentration being 0.2 mg/ml. aAlD was 
solubilized from the urea-insoluble pellet 
by dialysis against a buffer containing 
glycerol: 50 mM Tris, pH 8.0, 50 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 1 mM 
PMSC, 10% glycerol. This dialysis step 
was simultaneously considered as a reag-
gregation step. After 2.5 fold concen­
tration by ultrafiltration (Amicon 5), 
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200 μΐ of the sample, containing 5 mg 
protein per ml, was applied to the gel 
nitration column. 
time of 6 h. All samples were analysed by 
Tricine SDS-PAGE. 
Crosslinking 
Crosslinking was performed according to 
Siezen et al. [38], with minor modifica­
tions. The WSF of an induced 
pET3baA2D culture was dialysed over­
night at 4°C against 0.2 M triethanol-
amine-HCl, 10 mM dithioerythritol, pH 
8.0. Dimethyl suberimidate was dissolved 
in the same buffer and within 1 minute of 
preparation it was mixed with the protein 
solution, to final concentrations of 
0.2-2S mM, final protein concentration of 
1 mg/ml, and pH 8.0 at 20°C. The reac­
tions were stopped after 2 h, by addition 
of SDS, up to a concentration of 1%, and 
immediate heating to 100°C for 2 nun. To 
achieve a higher degree of crosslinking, 
protein solutions were treated with higher 
concentrations of dimethyl suberimidate 
(up to 125 mM) and a ñnal incubation 
RESULTS 
Expression and purification of recom-
binant proteins 
Proteins and protein fragments can be 
directly expressed as unfused polypeptides 
in E.coli, using the pET-expression system 
[24]. DNA fragments coding for bovine 
αΑ-crystallin (residues 1-173) and for its 
putative N-terminal domain, aAlD (resi­
dues 1-63), were inserted in the Afcol-site 
of the expression plasmid pET8c, resulting 
in the constructs pET8caA and 
pET8caAlD, respectively (Fig. 1A,B). 
The fragment encoding the C-terminal 
domain and tail, aA2D (residues 64-173), 
was inserted in the ЛИеІ-site of plasmid 
рЕТЗЬ, resulting in the expression con­
struct pET3boA2D (Fig. 1С). 
The E.coli strain BL21(DE3) was used as 
Fig. 1: Diagrams of construction of expression plasmids for aA-crystallin (A) and its N- and 
C-terminal domains (B and C, respectively). Hatched boxes indicate DNA ведчтггв coding for bovine 
αΑ-crystallin (A), the N-terminal domain of bovine aA-crystalhn (B) and the C-terminal domain of rat 
αΑ-crystallin (C). (A) The cDNA BLaA-l (27) was partially digested with Ncol. The resulting ±870 bp 
fragment was further digested with НЫЛ. To insert the 511 bp Ncol-Hhnl fragment of BLaA-l into the 
expression vector pETUc, an unphospborylated ds oligonucleotide was synthesized, containing the codons 
specifying the last three amino acids of bovine aA-crystallm and a TAA stop codon, as well as а ВатШ 
overhang site at the 3' end and an Hhal overhang site at the 5' end. Insertion of the BLaA-l NaA-Hhal 
fragment and the Hhal-ВатШ. adaptor, resulted in the expression construct pETScoA. (B) The Ncol-
fragment of BLaA-l encoding residues 1-107 of bovine aA-crystalhn was digested with Ddel to obtain a 
186 bp fragment. To lígate this Ncol-Ddel fragment into the expression vector pETSc, a synthetic 
unphospborylated ds oligonucleotide was used containing the codon specifying residue 63 Clu of aA-
crystalhn, a TAG stop codon as well as a Ddel overhang site at the 5' end and an Ndel overhang site at the 
3' end. The 3' Ndel overhang was present because this adaptor was originally designed for insertion of the 
Nool-DdA fragment into the Ndel site of the рЕТЗЬ vector. The S'-ends of the Ncol-Ddel fragment and the 
Ddel-Ndel adaptor were consecutively ligated to the vector and to the fragment. To circularize the construct 
the Ndel overhang site of the adaptor and the ВатШ overhang-site of the vector were filled in, using T4 
DNA polymerase, the blunt ends phocphorylated and ligated. (C) The partial cDNA clone RLaA-1 (26) was 
digested with Hpall. The resulting Hpatl fragment encodes residues 68-173 of rat αΑ-crystallin. To insert 
this fiagmeut mio the expression vector рЕТЗЬ a synthetic unphospborylated ds oligonucleotide was 
synthesized containing the ATG translation initiation codon, the codons specifying amino acids 64-67 of rat 
aA-crystallin, an Ndel overhang ate at the 5' end and an HpaU overhang site at the 3' end. The HpàQ 
fragment was ligated with both its 5' end and its 3' end to the Ndel overhang sites of the рЕТЗЬ vector 
using the Ndel-Hpaü adaptor. P- f t / I . Nc-ЛГсоІ, Hh=flhal, B=&rniHl, D d O f e l , Нр-ЯраП, N d -
Ndel. 
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the expression host for pET8caA and 
pET8corAlD, and their expression pro­
ducts were isolated as described in Mate­
rials and Methods. Induction of pET8caA 
(Fig. 2A, lane 2) resulted in expression of 
a polypeptide with an apparent molecular 
weight a little smaller than the orA-crys-
tallin subunit isolated from calf lenses 
(Fig. 2A, lane 6). This difference may be 
A 1 г э 5 6 1 2 3 4 5 6 
due to the N-terminal acetylation of calf 
lens αΑ-crystallin, which does not occur 
in Exoli. The identity of the induced 
protein was confirmed by Western blotting 
with a polyclonal anti-orA antiserum (Fig. 
2A), and by amino acid analysis of tryptic 
peptides from the water-soluble bacterial 
lysate (data not shown). All expected 
peptides were present. The N-terminal 
peptide still contained the initiation 
methionine, as is the case in bovine αΑ-
crystallin. This was expected, since it has 
been shown that methionine followed by 
an aspartic acid residue will not be re­
moved in Exoli [39]. 
Recombinant αΑ-crystallin constitutes up 
В 1 2 3 4 5 1 2 3 4 5 
« 
' ^ - 1 2 1 
С I ¿ 3 4 5 6 1 2 3 4 5 6 
sii-- -67 -43 
-30 
-201 
Fig. 2: Overexpression and extraction of αΑ-
crystallin and its domains. Left naives of panels 
show CBB-stained protein patterns after SDS-
PAGE, right halves of panels corresponding immu-
noblots. Molecular size markers, in IcDa, are 
indicated. Arrowheads indicate the expressed pro­
teins. (A) Lanes 1 and 2, total protein of E.coli 
BL21(DE3) containing plasmid рЕТвсоА, nonindu-
ced and induced, respectively. Lanes 3, 4 and 5, 
water-soluble, urea-soluble and urea-insoluble 
fraction, respectively, of the induced bacterial 
lysate. Lane 6, αΑ-crystallin isolated from calf 
lenses, as a control and a molecular weight marker. 
Samples were electrophoresed in a 13% SDS-PAA 
gel. The Western blot was reacted with a poly­
clonal antiserum, against calf αΑ-crystallin. (B) 
Lanes 1 and 2, total protein of E.coli BL21(DE3) 
containing plasmid pETBcoAlD, noninduced and 
induced, respectively. Lanes 3, 4 and 5, water-
soluble, urea-soluble and urea-insoluble fraction, 
respectively, of the induced bacterial lysate. Sam­
ples were electrophoresed in a Tricine SDS-PAA 
gel. The Western blot was incubated with a poly­
clonal antiserum directed against residues 49-63 of 
αΑ-crystallin. (C) Lanes 1 and 2, total protein of 
E.coli BL21(DE3)pLysS containing plasmid 
pET3baA2D, noninduced and induced, respective­
ly. Lanes 3, 4 and 5, water-soluble, urea- soluble 
and urea-insoluble fraction, respectively, of the 
induced bacterial lysate. Lane 6, aA2D, purified 
by affinity chromatography. Samples were electrop­
horesed as in (B). For the Western blot. Ine mono­
clonal antiserum Cr.I-1, reacting with C-terminal 
sequences of rat αΑ-crystallin, was used. 
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to 60% of total bacterial protein, as es­
timated by gel scanning. The bacterial 
lysate was divided into a water-soluble 
fraction (WSF), a urea-soluble fraction 
(USF) and a urea-insoluble fraction (UIF). 
PAGE demonstrated that most of the 
recombinant αΑ-crystallin chain is in the 
WSF (Fig. 2A), however it contains only 
40% recombinant αΑ-crystallin, as es­
timated by gel scanning. Since the WSF 
recovered from a 500 ml culture contains 
80-150 mg protein, 30-50 mg αΑ-crystal-
Time(mm) 
ess 
Fig. 3: Gd permeation analysis of recombinant αΑ-crystallin. (Top) Absorbance profile of the water-
soluble friction of induced E.eoli BL21(DE3) containing plasmid pETBcaA, after Superóse 6B chromato-
graphy. Elution positions of gel filtration markers as well as HMW and LMW bovine a-crystallin are 
indicated above the peaks. (Bottom) CBB-stained pattern after Tricine SDS-PAGE of alternate gel filtration 
fractions. Lanes correspond with the fractions directly above them in the elution partem. The first lane 
represents the composition of the sample applied onto the gel filtration column. The arrowhead indicates the 
position of recombinant аА-стуйаІІш. 
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lin is present in the WSF. Small amounts 
aie in the USF and UIF, which typically is 
also the case for or-crystallin from bovine 
lenses [40]. 
Induction of pETUcaAlD resulted in the 
expression of a protein with an apparent 
molecular mass of about 7 kDa, which is 
the expected size for this oligopeptide (7.4 
kDa) (Fig. 2B). α A ID accounts for about 
40% of the total bacterial protein. The 
expressed protein is not recognized by 
polyclonal antibodies against aA-crystallin. 
We therefore used a polyclonal antiserum 
raised against residues 49-63 of calf aA-
crystallin [34]. Unfortunately this anti­
serum cross-reacts with a number of bacte­
rial proteins, since the immunized rabbit 
was contaminated with Exoli. However, a 
strong signal from a 7 kDa protein is only 
obtained after induction of the 
pET8caAlD bearing strain. The identity 
of the expressed protein in the USF was 
confirmed by analysis of its tryptic pep­
tides. All expected tryptic peptides were 
present, be it with contaminations due to 
the presence of other proteins in the USF. 
As can be seen from the molar ratio of the 
amino acid composition of Tl: 1.4 Asp(l), 
1.3 Glu(l), 1.0 Pro(l), 1.2 Ala(l), 0.8 
Met(l), 1.7 Ile(2), 0.9 Phe(l), 0.8 
His(l), 1.0 Lys(l) and Trp(l) (expected 
values [36] in brackets), the N-terminal 
methionine was not removed, like in re­
combinant aA-crystallin. The other pep­
tides we found were: T2: Arg(l), T3: 1.0 
Thr(l), 1.0 Ser(l), 2.0 Pro(2), 1.1 
Gly(l), 1.1 Leu(l), 0.8 Tyr(l), 1.0 
Phe(l), 1.0 Arg(l); T5: 0.8 Ser(l), 1.2 
Glu(l), 1.0 Leu(l), 0.9 Phe(l), 1.1 
Arg(l) and the expected part of T6: 1.2 
Asp(l), 1.0 Thr(l), 1.7 Ser(2), 1.2 
Glu(l), 1.1 Gly(l), 1.0 Val(l), 0.8 Пе(1), 
1.0 Leu(l). The large and hydrophobic 
peptide T4 cannot be recovered by peptide 
mapping or RP-HPLC [36,3η. WSF, USF 
and UIF were also obtained for this strain. 
From Fig. 2B, lanes 3-5, it is clear that 
aAlD is not expressed as a water-soluble 
protein. The expressed protein is partially 
urea-soluble but considerable amounts 
remain in the urea-insoluble fraction. It 
may be that this protein is not properly 
folded, and as a result precipitates, co-
precipitating a number of bacterial proteins 
(Fig. 2B, lane 5). To solubilize the pro­
teins of the UIF, the UIF was dialysed 
against a glycerol-containing Tris-buffer 
(Materials and Methods). By this method 
almost all urea-insoluble proteins were 
dissolved, including aAlD. Once solubi-
lized we could use aAlD for aggregation 
studies. 
Chicken egg white lysozyme, used to lyse 
Exoli BL21(DE3) cells, has roughly the 
same molecular weight as aA2D. There­
fore the strain Exoli BL21(DE3).plysS 
was used as the expression host for 
pET3baA2D. This strain contains the 
plasmid pLysS, coding for THysozyme, 
so lysis is simply performed by freeze-
thawing [24]. Induction of the 
pET3baA2D bearing strain led to the 
production of a protein with an apparent 
Fig. 4: Gd permeation analysis of affinity puri­
fied and reaggrcgated recombinant aA2D. 
Absofbance profile after Superóse 6B chromato-
graphy of recombinant aA2D, purified by affinity 
chromatography from the water-soluble fraction of 
induced E.coli, containing plasmid pET3borA2D, 
denatured in 6 M urea and reaggiegated by dialy-
sis. The first peak contains aA2D. The latter two 
peaks do not contain any proton, as was assessed 
by SDS-PAGE and amnio acid analysis. Elution 
positions of gel filtration markers are indicated. 
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molecular mass of 14 kDa (Fig. 2C), 
which is slightly higher than the expected 
size of aA2D (12.4 kDa). aA2D accounts 
for about 20% of total cell protein. The 
expressed protein is recognized by the 
monoclonal antibody Cr.I-1, directed 
against an epitope near the C-terminus of 
rat orA-crystallin [32]. To further confirm 
the identity of the expressed protein, 
aA2D was isolated by isotachophoresis, 
after SDS-PAGE. Tryptíc peptides of thus 
punned aA2D were analysed (data not 
shown). Indeed, all expected peptides were 
present. However, it turned out that, the 
initiation methionine was not efficiently 
removed in Exoli. This was not expected, 
in this case, since from the literature it 
appears that methionine with an adjacent 
valine should be removed for 90% [39]. 
Again WSF, USF and UIF were separa-
ted. Clearly, aA2D is expressed as a 
water-soluble protein (Fig. 2C, lanes 3-5). 
Moreover, <*A2D is not degraded by 
bacterial proteases during expression in 
Exoli. These two facts indicate that a 
stable, properly folded structure has been 
formed [41]. aA2D was separated from 
bacterial proteins by affinity chromato-
graphy, as described in Materials and 
Methods (Fig. 2C, lane 6). 
Aggregation behaviour of recombinant 
otA, oALD and crA2D 
To check whether native-like aggregates of 
recombinant aA-crystallin are formed 
during expression in Exoli, the crude 
WSF, containing recombinant aA, was 
applied onto a Superóse 6B gel filtration 
column. From Fig. 3 it appears that the 
recombinant aA-crystallin indeed forms 
700-800 kDa aggregates, that are well 
corresponding in size with the a-crystallin 
aggregates in the WSF of calf lenses [1]. 
This finding indicates that recombinant 
aA-crystallin is properly folded and ag-
gregated in Exoli. Apparently, the ab-
sence of modifications, like N-terminal 
acetylation [36] and phosphorylation [37] 
does not influence the ability of forming 
aggregates of the proper size. 
Prior to the determination of the molecular 
mass of aA2D, this protein was purified 
by affinity chromatography, denatured in 
6 M urea and reaggregated as described in 
Materials and Methods. Pure reaggregated 
aA2D was applied to the Superóse 6B gel 
filtration column. The elution profile in 
Fig. 4 shows three peaks of which the first 
contains orA2D, as established by SDS-
PAGE. The first peak corresponds with a 
protein with an estimated molecular mass 
of 60 kDa, indicating that reaggregated 
aA2D is rather an oligomer than a poly-
mer. When applying the crude WSF of 
«"M* > « » ¡яит ІКщЛ < 
1 2 3 4 5 6 
Fig. 5: Western blot of orosslinked recombinant 
aA2D. Crosslinking of bacterial WSF, at 1 mg/ml 
protein, for 2 h at 20°C, in 0.2 M triethaiiolamine-
HCI (pH 8.0), 10 fflM dithioerythritol, using 
0 mM, 0.2 mM, 1 mM, 5 mM and 25 mM of 
dimethyl suberimidate (lanes 1-5, respectively). 
The sample in lane б was incubated for 6 b at a 
final concentration of 125 mM suberimidate, 
obtained by adding fresh aliquota of 25 mM each 
hour. A trace amount of dimeric aA2D is always 
present in the control non-crosslinked samples, 
despite the presence of B-mercaptoethanol. Im-
munoblotting was performed with the monoclonal 
antibody Cr.I-1. Arrowheads indicate the positions 
of the mono-, di-, tri- and tetramere of aA2D. The 
arrow shows the boundary between (tacking and 
resolving gel. 
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pET3baA2D directly to the Superóse 6B 
column the same result was obtained (data 
not shown). Gel permeation chromato-
graphy thus reveals that crA2D probably 
forms tetramere or pentamers. The quater-
nary structure was further analysed by 
cross-linking with dimethyl suberimidate 
(Fig. 5). The subunits of oA2D oligomers 
in the bacterial WSF were cross-linked at 
a total protein concentration of 1 mg/ml, 
to avoid interaggregate cross-linking. With 
increasing cross-linker concentrations, up 
A280 
50 
Time I mm) 
*' 5*κ Sii, 
•«» 
Fig. б: Gd permeation analysis of recombinant aALD. (Top) Absoibance profile of tbe aolubibzed urea 
insoluble fraction of induced E.eoli BL21(DE3), containing plasmid pET8caAlD, after Superóse 6B 
cbxomalogTBpby. Elution positions of gel filtration markers as well as HMW and LMW α-crystallin are 
indicated above tbe peaks. The dashed Ime indicates the estimated presence of orAlD at an arbitrary scale. 
(Bottom) Pattern of alternate gel filtration fractions after Tríeme SDS-PAGE. Lanes correspond with the 
fractions directly above them in the elution pattern. The first lane presents the composition of the sample 
applied to the gel filtration column. The arrowhead indicates the position of orAlD. 
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to 25 raM, aA2D forms predominantly 
dimers. Longer incubations, with repeated 
additions of a fresh portion of cross-linker, 
results in the formation of trimers and, 
clearly more strongly, tetramers. No 
greater multimers can be observed, except 
from some polymerized protein that is 
unable to penetrate the resolving gel. 
These results demonstrate that the aA2D 
oligomers occur as dimers or tetramers, 
the latter apparently consisting of a dimer 
of dimers. 
To estimate the aggregate size of aAlD 
the urea-insoluble fraction was dialysed 
against a glycerol-containing Tris-buffer 
(Materials and Methods) to simultaneously 
solubilize and reaggregate otAlD. A sam-
ple containing 1 mg of protein was applied 
to the Superóse 6B column. From Fig. 6 it 
appears that aAlD is able to form very 
large aggregates, ranging in size between 
HMW-a-crystallin (> 1,200 kDa) and 
LMW-a-crystallin (800 kDa). Alternative-
ly, the USF of aAlD, in which the protein 
concentration (1 mg/ml) is considerably 
lower than in the solubilized UIF, was 
dialysed against the Superóse 6B elution 
buffer, and analysed by gel filtration with-
out prior ultrafiltration. Also in this case 
orAlD eluted after about 15 minutes, 
which corresponds well with the elution 
time found for aAlD from the solubilized 
UIF. 
DISCUSSION 
Recombinant aA-crystallin behaves like a-
crystallin isolated from eye lenses, in 
terms of aggregation behaviour and solubi-
lity. Also, recombinant aA-crystallin is 
not susceptible to proteolytic cleavage 
during production in E.coli. This indicates 
that recombinant aA-crystallin has a stable 
conformation [41]. Apparently aA-crys-
tallin is similarly folded and aggregated, 
whether it is expressed in E.coli or in lens 
cells. Unfortunately, not knowing any de-
tails of the biological functioning of aA-
crystallin precluded the application of 
assays to establish the functional integrity 
of recombinant aA. 
The fact that also aA2D is water-soluble 
and not susceptible to bacterial proteases 
again indicates that it is in a stable form, 
probably corresponding with its native 
conformation in the aA subunit. Urea 
denaturation and »aggregation of calf lens 
α-crystallin at low protein concentrations 
(<0.3 mg/ml) yields α-crystallin with an 
intact secondary and tertiary structure, as 
established by fluorescence and far ultra­
violet circular dichroism measurements 
[42] and electron microscopy [19]. Urea 
denaturation and reaggregation of purified 
aA2D likewise yields oligomers with the 
same size as those formed directly in 
E.COÜ. It is, therefore, reasonable to as-
sume that aA2D is properly folded. Its 
'aggregation behaviour', i.e. the formation 
of dimers or tetramers, might thus be 
indicative for the interactions of this do-
main in its native environment, as part of 
the α-crystallin aggregate in the lens. 
Unfortunately, reaggregation of aAlD at 
lower protein concentrations, to prevent 
superaggregation and precipitation, led to 
dramatic loss of aAlD during ultrafil­
tration steps. This may be caused by stick­
ing of this hydrophobic polypeptide to the 
ultrafiltration membrane. However, ag­
gregates obtained by reaggregation of 
relatively pure aAlD (the USF of Fig. 
2B, lane 4), at a protein concentration of 1 
mg/ml, have the same large size as ag­
gregates formed during reaggregation of a 
protein mixture containing aAlD at higher 
protein concentrations. For α-crystallin it 
has been found that reaggregation of up to 
50 mg/ml of pure α-crystallin results in 
aggregates that all have similar sizes [42]. 
It thus appears that, in contrast to aA2D, 
aAlD forms very large aggregates, under 
the conditions used. This is in accordance 
with earlier findings of Siezen et al. [17]. 
They observed that C-terminally truncated 
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αΑ subunits, obtained by partial tryptic 
digestion, generally tended to form larger 
aggregates the more of the C-terminus was 
cleaved off. The pronounced tendency of 
aA-crystallin to form large aggregates thus 
seems associated with the more hydro­
phobic N-terminal domain. This finding 
could be taken to fit the micellar model for 
a-crystallin as proposed by Augusteyn and 
Koretz [21]. Protein "micelles" might be 
formed through hydrophobic interactions 
between the N-terminal parts of the am-
phiphilic a-crystallin subunits. However, 
on basis of our data we can not exclude 
the possibility that aAlD is not an inde­
pendent domain and that its aggregates are 
being formed through non-specific interac­
tions, caused by inproper folding. 
The aggregation properties of a-crystallin 
and the small HSPs are in all probability a 
crucial aspect of their biological functio­
ning. It is known since long that a-cryst­
allin in the eye lens forms larger ag­
gregates (HMW-a) upon ageing and 
during cataractogenesis [1,2]. The ag­
gregate size of a-crystallin is, among 
others, influenced by calcium ion con­
centration [43], temperature [44] and the 
presence of low molecular weight ft- and 
γ-crystallins [45]. In the rat heart orB-
crystallin forms larger aggregates upon 
ischemia, a phenomenon that also takes 
place when the cytoplasmic fraction of 
control hearts is exposed to slightly acidic 
pH (6.5-7.0) [46]. The complexes of 
small HSPs likewise increase dramatically 
in size upon heat shock [11]. 
Our results agree with earlier suggestions 
of a two-domain structure for the a-crys­
tallin subunits [22,23]. Further characteri­
zation of these now available domains of 
aA-crystallin, and of the corresponding 
domains of aB-crystallin and small HSPs, 
will contribute to solving the structure-
function relationship of this intruiging 
family of proteins. 
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CHAPTER 4 
Comparison of the homologous carboxy-terminal domain and tail of 
a-crystallin and small heat shock protein 

Comparison of the homologous carboxy-terminal domain and tail of 
α-crystallin and small heat shock protein 
The cf-crystallins and mull beat shock proteins (HSPs)1 are structurally and functionally related. Especially 
(he primary structure of their C-terminal domains is well-conserved. To study the significance of this 
feature, the С-terminal domain and tail of rat αΑ-crystallin and of mouse HSP2S were expressed in E.coli, 
and purified. The corresponding region of bovine orB-crystalun was obtained by cleavage of the protein with 
cyanogen bromide. Secondary structure analysis showed that all three domains have primarily 0-sheet 
conformation and contain at most 10% of or-belix, like the proteins from which they are derived. Although 
the secondary structure thus appeared to be conserved in the three polypeptides, the quaternary structure 
was not. The C-terminal part of aA-crystallin has previously been shown to form dimers or tetramere, 
while the corresponding regions of aB-cryslallin and mouse small HSP now appear to form larger 
aggregates. It has recently been shown that α-crystallin and small HSPs suppress heat-induced aggregation 
of proteins, and promote refolding of chemically denatured proteins. Although the C-terminal domains and 
tails of the three proteins apparently form viable structures, they did not show any heat protection activity. 
Finally, in the course of this study the primary structure of the C-terminal part of the mouse small beat 
shock protein was deduced from its cDNA sequence and confirmed by partial protein sequencing. Some 
differences with the previously published smino acid sequence were observed and a revision is therefore 
proposed. 
INTRODUCTION 
α-CrystaUin, a major component of the 
vertebrate eye lens, forms large water-
soluble aggregates (300-1000 kDa), com­
posed of two types of homologous sub-
units, aA and orB (20 kDa) [1-3]. The a-
crystallins are evolutionarily, structurally 
and functionally related with the ubiquitous 
small HSPs [4-6]. They are members of 
the a-crystallin/small HSP family [6,7]. 
Both α-crystallin subunits occur outside 
the lens. αΑ-Crystallin is found at very 
low levels in spleen and thymus [8], 
whereas aB-crystallin is expressed at 
higher levels, notably in heart, striated 
muscle and kidney [9-11]. Extralenticular 
aB-crystallin behaves as a small HSP [12]. 
Both a-crystallin and the small HSPs have 
been shown to have the properties of a 
molecular chápenme [13-15]. Both pro-
teins form large aggregates, which is 
obviously related to their common func-
tional features. However, no conclusive 
data about their quaternary structure is yet 
available. Different models for the arran-
gement of subunits in α-crystallin have 
been proposed, ranging from a multi-layer 
to a micellar arrangement of subunits 
[16-19]. A way to get more information 
about the quaternary structure is to find 
the regions that are involved in intersub-
unit interactions. The α-crystallin and 
small HSP subunits are probably composed 
of two compact structural domains and an 
extending C-terminal tail [20]. It has been 
1
 The abbreviations used are: HSP(s), heat shock protein(s); HSP2S, mouse small HSP; aA2Dt, 
residues 64-173 of rat a-crystallin; aB2Dl, residues 70-175 of bovine aB-crystallin; HSP2Dt, 
residues 92-209 of HSP25; bp, base pair; PMSF, phenylmethylsulfonyl chloride; WSF, water-
soluble fraction; SDS, sodium dodecyl sulfate; PAGE, Polyacrylamide gel electrophoresis; PAA, 
Polyacrylamide; PCR, polymerase chain reaction; TCA, trichloroacetic acid. 
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proposed that the C-terminal domain, 
which is the best conserved sequence 
within this protein family, is the 
'aggregation domain' [4]. We previously 
showed that the C-terminal domain and tail 
of otA-crystallin forms dimers or tetra­
mere, whereas the N-terminal domain of 
αΑ-crystallin aggregates into less defined 
large complexes [21]. Based on this fin­
ding, a new model for the quaternary 
structure of or-crystallin and the small 
HSPs has been proposed, in which a 
rhombic dodecahedric arrangement of 
tetrameric building blocks occurs [22]. 
We now address the question as to 
whether also the corresponding C-terminal 
sequences of aB-crystallin and a small 
HSP form tetramere. Therefore we pro­
duced the C-terminal sequences of bovine 
aB-crystallin and mouse HSP2S, and 
analysed their quaternary structures by gel 
permeation chromatography and crosslink-
ing. Far UV circular dichroism spectro­
scopy was used to check the presence of 
regularly folded structure, and to find out 
whether the secondary structure of the C-
terminal domains and tails is conserved. 
We further investigated whether the heat-
protective capacity of the a-crystallin 
subunits and HSP25 is associated with the 
homologous C-terminal sequences. 
MATERIALS AND METHODS 
Bacterial strains, plasmids and reagents. 
Escherichia coli strains HB101 [23] and 
TGI [24] were used as recipients for the 
constructs pAK3038p25 [25] and 
pET3bHSP2Dt, respectively. For over­
production of HSP2Dt, E.coli strain В 
BL21(DE3)pLysS [26] was used. The 
construction of pAK3038p25 has been 
described earlier [25], and pET3baA2Dt 
* 10 20 * 30 40 
HSP2Dt MIRQTADRWRVSLDVNHfA. PEELTVKTKEGWEITGKHEERQ 
aA2Dt MVRSDRDKFVIFLDVKHFS PEDLTVTVLEDFVEIHGKHNERQ 
oB2Dt RLEKDRFSVNLDVKHFS PEELKVKVLGDVIEVHGKHEERQ 
HSP2Dt 
oA2Dt 
<xB2Dt 
* 50 60 * 70 *80 
DEHGYISRCFTRKYTLPPGVDPTLVSSSLSPEGTLTVEA 
DDHGYISREFHRRYRLPSNVDQSALSCSLSADGMLTFSG 
DEHGFISREFHRKYRIPADVDPLAITSSLSSDGVLTVNG 
* * * 
90 100 110 120 
HSP2Dt PLPKAVTQS—A,EITIPVTFESRAQIGGPEAGKSEQSGAK 
aA2Dt PKVQSGLDAGHSERAIPVSREEKPSSAPSS 
aB2Dt PRKQASG PERTIPITREEKPAVTAAPKK 
^ ^ ^ ^ » ^ ^ • ^ » ^ P ^ P ^ P N ^ S r f 
Figure 1: Alignmait of the homologous С-terminal domains and tails of the mouse small beat shock 
protein, rat aA-crystallin and bovine aB-crystallin [<]. The aligned sequences are displayed in three 
blocks, (he first two corresponding with the two putative motifs in the С-terminal domain of a-crystallin, 
and the last one representing the С-terminal extension, as proposed by Wistow [20]. Lysine residues are 
printed ш bold-type. The conserved aspartyl, prolyl and glycyl residues are indicated by an asterisk. At the 
bottom, putative interacting regions are represented. The very flexible C-terannal tail of oA- and orB-
crystallin [37] is represented by the wavy line. The original sequence of HSP2DI [25] was corrected as 
follows: 8(dcl-»R), 18(V-»F), 19(I-»A) and 96(T-A), and are underlined. 
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has previously been prepared in our labo­
ratory [21]. Ampicillin, chloramphenicol, 
IPTG, DNAase I, proteinase inhibitors and 
proteinase К were obtained from Sigma. 
Restriction enzymes, T4 DNA ligase and 
T4 polynucleotide kinase were purchased 
from Bethesda Research Laboratories 
(BRL), whereas Taq-polymerase was 
obtained from Perkin-Elmer. The cross-
linking agent dimethyl suberimidate was 
from Pierce. Oligonucleotides were syn­
thesized using a Cyclone Plus DNA syn­
thesizer from Milligen/Biosearch. 
Polymerase chain reaction and cloning 
procedures 
Polymerase chain reactions were per­
formed in a total volume of SO μΐ, and 
contained 20 mM Tris/HCl, pH 8.0, SO 
mM KCl, 2.5 mM MgCl2, 0.1 mg/ml 
BSA, 0.2 mM dNTPs, 0.2 μΜ primers, 
- 1 0 pg of pAK3038p25 and 1.25 U of 
Taq-polymerase. After an initial incubation 
at 95 e C for 8 min, 30 cycles were run. 
The first cycle consisted of 2 min at 95 °C, 
1 min at 51°C, and 2 min at 72eC. At 
each subsequent cycle, the elongation step 
was extended with 2 sec. After 30 cycli an 
extra incubation of 2 min. at 72"C was 
performed. The final reaction mixture was 
consecutively extracted with phenol/chlo­
roform (1:1, v/v) and chloroform. It was 
then treated with proteinase К 
(0.5 mg/ml), extracted again with phe­
nol/chloroform and chloroform, and stored 
at -20eC. 
The DNA fragment (604 bp) obtained 
from the amplification reaction was diges­
ted with Ndel and BamHI and inserted in 
the expression plasmid рЕТЗЬ. Plasmid 
DNA (pET3bHSP2Dt) was sequenced by 
the dideoxynucleotide method [27] and 
transformed in BL21(DE3)pLysS cells. 
Expression and purification of proteins 
aB-Crystallin was obtained from calf 
lenses as described [28]. Bovine 0L-crys-
tallin was purified by gel filtration [28]. 
Recombinant bovine oA-crystallin and 
mouse HSP25 were isolated according to 
Merck et al. [14] and Gaestel et al. [29], 
respectively. To be able to distinguish 
between the C-terminal domain with and 
without the extending tail, we will further 
refer to the former as 2Dt and to the latter 
as 2D. oA2Dt (previously aA2D) was 
expressed in E.coli. A water-soluble frac­
tion of the E.coli lysate was obtained as 
described [21], dialysed against demine-
ralized water, containing proteinase in­
hibitors (20 μΜ PMSF, 100 μΜ EDTA, 
40μ^1 bacitracin and 30 μg/l benzamidin) 
and lyophilized. 100 mg of lyophilized 
aA2Dt WSF was dissolved in starting 
buffer (1 mM sodium phosphate, pH 6.8), 
containing the above mentioned proteinase 
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Figure 2: Construction of the HSP2Dt expresión 
vector. The clone pAK3038, containing the full-
length cDNA of mouse HSP2S [25] was used to 
amplify the fragment encoding HSP2Dt by the 
polymerase chain reaction. The resulting DNA 
fragment of 604 bp was cleaved with Ndel and 
BamHI and cloned in the Ndel/BamHI-cleaved 
рЕТЗЬ vector to yield the pET3bHSP2Dt construct. 
ID, 2Dt and nc are the nucleotide séquences cor-
responding with the N-tenninal domain, C-terminal 
domain and tail, and the 3' non-coding region, 
respectively. Lower case letters in the N-tenninal 
primer denote mismatches, to introduce an Ndel 
site. 
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inhibitors, and loaded on a Bio-Gel 
hydroxylapatite column (Bio-Rad), equi-
librated with starting buffer. Proteins 
were eluted at a linear flow rate of 0.47 
cm/min and with a linear gradient of 
sodium phosphate (1.4 mM/min). Frac-
tions containing aA2Dt were pooled, 
dialysed against water (containing the 
above-mentioned proteinases) and lyophil-
ized. Prepurified aA2Dt was dissolved in 
water, containing 0.1% TFA at the highest 
protein concentration possible (2-10 
mg/ml). 1 ml of the dissolved sample was 
loaded on a reversed phase HPLC column 
(RP-4, Selectosil, 5C4, 300 À) with di-
mensions of 250 mm χ 4.6 mm. Proteins 
were eluted at a flow rate of 0.8 ml/min 
and with a gradient of acetonitrile in 0.1 
% TFA. Fractions containing the desired 
polypeptides were pooled and lyophilized. 
HSP2Dt was expressed using the bacterial 
strain BL21(DE3).pLysS containing the 
plasmid pET3bHSP2Dt. The expression of 
the construct and the preparation of water-
soluble, urea-soluble and urea-insoluble 
fractions were performed as described 
previously [21]. HSP2Dt was directly 
punned from the WSF by RP-4 chroma­
tography. 
crB2Dt was obtained by cyanogen bromide 
cleavage of orB-crystallin according to 
standard procedures [30]. aB2Dt was 
isolated by RP-4 chromatography, as 
described above. 
Reaggregation 
Reaggregation was performed essentially 
as described earlier [14]. For crosslinking 
experiments, samples were dissociated in 
6 M urea, diluted with 0.2 M tri-
ethanolamine-HCl (pH 8.0) to a final 
concentration of 1 M urea and 0.4 mg/ml 
of protein and dialysed against this buffer. 
For measuring heat protection activity and 
CD spectra the dissociated samples were 
diluted with water to a final concentration 
of 1 M urea and 1 mg/ml of protein, 
dialysed against water and lyophilized. All 
solutions used for reaggregation contained 
SO mM of 0-mercaptoethanol and prot­
einase inhibitors as indicated above. 
Secondary structure estimation 
Information about the secondary structure 
was obtained by far UV CD spectroscopy. 
CD measurements were carried out using a 
Jasco Model 600 spectropolarimeter. A 
0.S0 mm pathlength cell was used. Reag-
gregated proteins were dissolved in SO 
mM sodium phosphate buffer, containing 
0.1 M NaCl, pH 7.0. Protein concentra­
tions were determined by amino acid 
analysis. The spectra, an average of 8 
scans, are normalized to a concentration of 
25 μΜ. The α-helix content was estimated 
according to Greenfield and Fasman [31]. 
Miscellaneous methods 
The N-terminal amino acid sequence of 
HSP2Dt was determined on an Applied 
Biosystems Model 470A Protein Sequen­
cer, equipped on-line with a Model 120A 
PTH Analyser. Gel permeation analysis 
was carried out, using a Superase 6 HR 
10/30 prepacked column (Pharmacia-LKB) 
[21]. Samples containing approximately 25 
/ig of protein were applied to the column 
and absorbance was measured at 225 nm. 
To calibrate the gel filtration column, 
molecular mass markers from the Phar­
macia gel filtration calibration kit were 
used. Crosslinking was performed with 25 
mM of dimethyl suberimidate, as descri­
bed earlier [13,21]. Crosslinking samples 
were analysed by Tricine SDS-PAGE [32] 
after TCA precipitation. The heat protec­
tion assay was performed as described 
earlier [14]. All samples used for the heat 
protection experiments were dissolved in 
50 mM sodium phosphate buffer, pH 7.0 
containing 0.1 M NaCl. They were then 
centrifuged at 20,000 rpm for 20 min. 
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RESULTS 
To compare the properties of the C-ter-
minal domain with extending tail (ab­
breviated as 2Dt) of crA-crystallin, aB-
crystallin and mouse HSP2S we could use 
previously described procedures to pro­
duce aA2Dt and oB2Dt, but had to con­
struct first an expression plasmid for 
HSP2Dt. The respective sequences of the 
three proteins are aligned in Fig. 1. 
Construction and sequence of 
pET3bHSP2Dt 
Fig. 2 summarizes the strategy chosen for 
the creation of a clone capable of directing 
the synthesis of the C-terminal domain and 
tail of HSP2S, by means of the polymerase 
chain reaction. The clone pAK3038p25, 
containing the full-length cDNA of mouse 
HSP25 [25] was used to amplify the de­
sired fragment. This fragment starts at 
nucleotide 364 of the cDNA p25, cor­
responding with isoleucine-92 of mouse 
HSP2S [25], and comprises the 3' se­
quence of the p25 cDNA, including the 
entire 3' noncoding region, as well as 69 
nucleotides downstream from the ВатШ 
cloning site of pAK3038p25 [25]. The 5'-
primer used in the reaction contained 
mismatches to introduce an Ndel restric­
tion site and a translation initiation codon. 
The DNA fragment encoding HSP2Dt was 
cloned into the рЕТЗЬ expression vector 
and transformed. To check whether or not 
mutations had occurred during the poly­
merase chain reaction, the insert was 
sequenced. Several differences with the 
expected sequence [25] were detected. The 
inferred differences corresponded with 3 
amino acid substitutions and the insertion 
of one amino acid (see Fig. 1). Three of 
these differences were limited to the nucle­
otide sequence corresponding with the 22 
N-terminal residues, so we resorted to N-
terminal protein sequencing and confirmed 
that the amino acid sequence corresponded 
with the nucleotide sequence. The results 
of our protein and DNA sequencing are 
depicted in Fig. 1. Our corrected amino 
acid sequence of HSP25 better corresponds 
with that of Chinese hamster HSP27 [33] 
and human HSP27 [34,35]. 
Purification of aA2Dt, aB2Dt and 
HSP2Dt 
A prepuriñcation of orA2Dt from the 
water-soluble fraction of an E.coli strain 
overexpressing aA2Dt [21] was performed 
by hydroxylapatite chromatography, result-
ing in about 80% pure aA2Dt (Fig. 3, 
lane 3). The elution profile of hydroxyl-
apatite chromatography is shown in Fig. 4. 
By virtue of the fact that a single internal 
methionine residue is present at position 
В 
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-20 
-14.4 
Flg. 3: Purification and crasslinldng of aA2Dt, 
aR2Dt and HSP2DL (A) Tricine SDS-PAGE 
pattern of samples taken during the purification 
procedure of aA2Dt, aB2Dt and HSP2JX Lane 1, 
total protein of E.coli BL21(DE3).pLysS, contain­
ing plasmid pET3baA2Dt without induction. Lane 
2, WSF of mis strain, after induction. Lane Э, 
aA2Dt after hydroxylapatite chromatography of die 
WSF of oA2Dt. Lane 4, aA2Dt after hydroxyl 
apatite and RP-4 chromatography. Lane 5, WSF of 
induced E.coli BL21(DE3).pLysS, containing 
plasmid pET3bHSP2Dt. Lane 6, HSP2Dt after RP-
4 chromatography of the WSF of this strain. Lane 
7, calf aB-crystallin. Lane 8, aB-crystallin after 
cleavage with cyanogen bromide. Lane 9, pure 
aB2Dt after RP-4 chromatography of cyanogen 
bromide cleaved aB-crystallin. (B) Tricine SDS-
PAGE pattern of crosslinked samples of HSP2Dt 
Gane 1), oA2Dt (lane 2) and oB2Dt Gane Э). SDS-
PAGE molecular mass marken are indicated in 
kDa. 
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Fig. 4: Hydroxylapatite dutíon pattern of the E.coli water-soluble fraction containing aA2Dt The 
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sodium phosphate gradient that was applied to elute aA2Dt. Fractions corresponding with an durian time of 
123-148 min (broken vertical lines) were collected, dialysed and lyophilized. 
67 in bovine orB, precisely proceeding the 
C-terminal domain [6], crB2Dt could simp-
ly be obtained by cleavage with cyanogen 
bromide. This resulted in a mixture of 
three polypeptides: uncleaved aB-crystal-
lin, residues 2-67 and residues 68-175 
(aB2Dt) (Fig. 3, lane 8). HSP2Dt was 
expressed in E.coli, after transformation of 
the construct pET3bHSP2Dt in 
BL21(DE3)pLysS, reaching levels of up to 
20 % of total protein (Fig. 3, lane S). The 
E.coli lysate was fractionated in a water-
soluble, urea-soluble and a urea-insoluble 
fraction. HSP2Dt turned out to be water-
soluble. 
The hydroxylapatite pool of aA2Dt, the 
CNBr cleavage mixture of aB-crystallin 
and the water-soluble fraction of the E.coli 
lysate containing HSP2Dt were applied to 
a reversed phase HPLC column of which 
typical elution patterns are shown in 
Fig. 5. Fractions containing the desired 
polypeptide were pooled and analysed by 
Tricine SDS-PAGE (Fig. 3). Although an 
analytical reversed phase column was used 
for the purification of the C-terminal 
domains, up to 10 mg of protein could be 
loaded on the column and a maximum of 3 
mg of pure protein (aB2Df) was obtained 
per run. Following the above procedures, 
a maximum of 10 mg of pure aA2Dt and 
HSP2Dt could be obtained from a 500 ml 
E.coli culture. 
Quaternary structure of ocA2Dt, oB2Dt 
andHSP2Dt 
Previously we showed that aA2Dt forms 
dimers or tetramers [21]. To investigate 
whether also the conserved C-terminal 
sequence of aB-crystallin and HSP25 
forms dimers or tetramers, we subjected 
the purified and reaggregated polypeptides 
to gel permeation chromatography 
(Fig. 6). In contrast with oA2Dt [21], 
both aB2Dt and HSP2Dt form large ag-
gregates. On basis of gel permeation mass 
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markers, molecular masses were estimated 
(Fig. 6). From the calibration line, shown 
in Fig. 6, it is obvious that the calculation 
of molecular masses gives not more than a 
rough indication. aB2Dt and HSP2Dt form 
aggregates of approximately 235 kDa 
(18-20 subunits) and 170 kDa (12-13 sub-
units), respectively. However, the elution 
profile of aB2Dt is very asymmetric, 
indicating that aB2Dt is a heterogeneous 
population of aggregates, with the largest 
aggregate consisting of 18-20 subunits. To 
further analyse the quaternary structure, 
the polypeptides were crosslinked by 
25 mM dimethyl suberimidate. In the case 
of orB2Dt more than 7 crosslinking pro-
ducts, all multiples of IS kDa, can be dis-
tinguished (Fig. 3B). However, in the case 
of HSP2Dt, predominantly dimers are 
formed, and only a faint tetramer band can 
be observed. This seems to be in contrast 
with the results obtained with the gel 
permeation experiment. A possible ex-
planation for this discrepancy is that the 
lysines of HSP2Dt are accessible to the 
crosslinker in a different manner than 
those of aB2Dt. It does, however indicate 
that HSP2Dt, like aA2Dt, occurs in a 
dimeric or tetrameric arrangement. 
Secondary structure of orA2Dt, <xB2Dt 
and HSP2DÍ 
All three domains are perfectly water-
soluble, indicating that no improper inter-
Fig. 5: Elution patterns of reversed phase chro-
matography of oA2Dt, aBZDt and HSP2DL The 
solid lines indicate elution patterns of the hydroxyl-
apatite pool of aA2Dt (A), the cyanogen bromide 
cleavage mixture of oB-crysUllin (B) and the WSF 
of the E.coli strain overexpressing HSP2Dt (C), 
chromatographed on a Selectosil RP-4 column. 
Absorbance was monitored at 225 nm. The broken 
lines indicate the gradient of acetomtrile (in %), 
used to elute the polypeptides. Vertical broken lines 
indicate the elution time range in which the desired 
polypeptides eluted. Corresponding fractions were 
collected, lyophilized and analysed by Triebe SDS-
PAGE (Fig. 3). 
actions between secondary structure ele-
ments, leading to aspeciñe aggregation, 
take place. Far UV CD measurements 
were performed, in order to provide addi-
tional evidence that the domains are pro-
perly folded, and that they contain the 
same secondary structure elements as a-
crystallin and HSP25, which are known to 
have predominantly /3-sheet structure and 
at most 10% of α-helix. Prior to CD 
spectroscopy, all investigated proteins 
were denatured and refolded under the 
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Figure 7: Far UV CD spectra of oA2Dt, nB2Dt and HSF2DL Panel A compares the CD spectra of 
aA2Dt (curve 1) and recombinant αΑ-crystallin (curve 2); panel В shows the CD spectra of aB2Dt (curve 
1) and calf aB-crystallin (curve 2); panel С compares the CD spectra of HSP2Dt (curve 1) and recombinant 
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same conditions. In Fig. 7, the normalized 
far UV CD spectra are shown. All three 
domains have curves that strongly re­
semble those of the proteins from which 
they are derived. The spectra differ in 
intensity, which is due to differences in 
molecular mass. It turns out that all pro­
teins and protein fragments contain at most 
10% of α-helix. This convincingly shows 
that, although the domains have different 
tendencies for oligomerizaäon, their se-
condary structures are similar and intact. 
Moreover, the secondary structures of the 
C-terminal domains resemble each other, 
like is also the case for the or-crystallin 
subunits and HSP25. 
Heat protection capacity of aA2Dt, 
aB2Dt and HSP2Dt 
It has recently been discovered that both 
or-crystallin and HSP2S can function as 
molecular chaperones [13-15]. To in-
vestigate whether this function can be 
assigned to the C-terminal domain and tail 
of these proteins, a heat protection experi-
ment was carried out. j9L-crystallin was 
heated in the presence of the C-terminal 
sequences of oA, orB and HSP2S. Heat 
denaturation of j9L-crystallin was moni-
tored spectrophotometrically. The heat 
denaturation curves are shown in Fig. 8. 
Obviously, none of the domains is capable 
of protecting 0L-crystallin against heat 
denaturation, despite the fact that they are 
apparently properly folded. 
DISCUSSION 
α-Crystallins and small HSPs are members 
of the same protein superfamily. All mem­
bers of the family are characterized by the 
presence of a common protein domain of 
about 90 residues, followed by an ex­
tension of variable length [4,6]. In Wis-
tow's model the common domain is pre­
ceded by a more variable N-terminal 
domain. The homologous C-terminal 
domain is composed of two similar struc­
tural motifs (Fig. 1) [20]. Most probably, 
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Figure 8: Heat-induced aggregation of /5L-crystalIm in the absence and presence of aA2Dt, aB2Dt and 
HSPZDt. In each experiment 0.16 mg of 0L-crystallin in a final volume of 0.4 ml was used. Aggregation 
of 0L-crystallin was measured either alone (curve 1 in panel А, В and C), m the presence of 0.05 mg of 
recombinant orA-crysUlhn (panel А, В and C, curve 3) or in the presence of 0.092 mg of aA2Dt (panel A, 
curve 2), 0.11 mg of aB2Dt (panel B, curve 2) and 0.074 mg of HSP2Dt (panel C, curve 2). The 
incubation temperature is indicated at the top of each panel. 
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the conserved C-terminal domain and 
extension are responsible for the common 
structural and functional properties of the 
α-crystallin/small HSP family. In this 
work we addressed the question whether 
the secondary and quaternary structure of 
this C-terminal sequence is conserved. 
Therefore, the C-terminal domain plus tail 
(2Dt) of rat aA-crystallin, calf aB-crystal-
lin and mouse HSP25 were isolated and 
subjected to gel permeation chromato­
graphy, crosslinking and CD spectroscopy 
after de- and renaturation. 
Far UV CD spectroscopy indicated that the 
three C-terminal domains and tails are 
structurally well organized, the secondary 
structure elements being predominantly 18-
sheet. At most 10% of α-helix is present. 
The same distribution of secondary struc­
ture elements is found in the proteins from 
which the C-terminal domains and tails are 
derived. This is in agreement with the 
proposal that the α-crystallin/small HSP 
subunits are composed of two domains 
with similar structural motifs [20]. The 
CD spectra thus indicate that the C-ter­
minal fragments are properly folded and 
can exist as independent structural units. 
The fact that the CD spectra of all protein 
fragments resemble each other, suggests 
that not only the primary structure but also 
the secondary structure has evolutionarily 
been conserved, as could be expected. 
The conservation of the interactions bet­
ween these protein fragments, however, is 
not obvious. Earlier, we showed that 
aA2Dt forms dimers or tetramers [21]. 
Gel permeation analysis of aB2Dt and 
HSP2Dt now revealed that these two do­
mains form larger aggregates. orB2Dt is 
most probably a heterogeneous population 
of differently sized aggregates, the largest 
aggregate consisting of about 18-20 sub-
units. HSP2Dt forms smaller but more 
homogeneous aggregates, comprising 
approximately 12-13 subunits. Covalent 
crosslinking experiments, however, show­
ed that HSP2Dt has a strong preference 
for dimers or tetramers and almost no 
higher crosslinking products are formed. 
On the other hand, aB2Dt is easily cross-
linked, resulting in the formation of high 
molecular weight crosslinking products. 
This apparent discrepancy could be due to 
the absence of free eamino groups on 
certain interacting surfaces, which would 
result in poor crosslinking. It is notewor­
thy that HSP2Dt, forming small oligomers 
of two or four subunits upon crosslinking, 
contains only 6 and 7 lysines, respectively, 
whereas aB2Dt contains 10 lysine residu­
es. Lysines are present at positions 6 and 
16 in aA2Dt and aB2Dt, but not in 
HSP2Dt. It might be that amino acids in 
the region 1-20 are involved in interactions 
between tetramers when larger aggregates 
are formed. This would explain why the 
subunits in HSP2Dt aggregates cannot be 
crosslinked by dimethyl suberimidate to 
polymers larger than tetramers. The fact 
that lysines are present at positions 29, 40, 
58, 87/88 and at the very C-terminal end 
in both HSP2Dt and aB2Dt, indicates that 
the regions around these lysines are not 
involved in contacts between tetramers. By 
examining the positions of other lysine 
residues, it appears that the lysines cor­
responding to the positions 29, 40 and 86-
88 are present in all three proteins. One or 
more of these lysine residues might thus 
be involved in crosslinking within tetra­
mers. It is conceivable that the region 
corresponding with positions 25-50 plays a 
role in the interactions between subunits 
within a tetramer. 
Wherever the positions of the interactive 
surfaces may be, the present results can be 
taken to fit the rhombic dodecahedric 
model for a-crystallin [22]. In this model 
it is proposed that a-crystallin and small 
HSP aggregates are made up of tctrameric 
building blocks. The interactions between 
subunits within a tetramer differ from 
those between tetramers. The fact that 
HSP2Dt can be crosslinked to tetramers, 
while forming per se large aggregates is 
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indeed an indication that two types of 
contacts exist. In this model it is also 
proposed that or-crystallin and small HSP 
aggregates may have no single quaternary 
structure, but at least one stable structure, 
the rhombic dodecahedron. The fact that 
aB2Dt apparently is a heterogeneous 
population of aggregates (Fig. 6) may in 
fact reflect that α-crystallin and small HSP 
aggregates are dynamic structures, with 
several possibilities for oligomenzation. 
Recently, it has been discovered that both 
α-crystallin and HSP2S have in vitro cha· 
perone activity [13-15]. From the sequence 
comparison of α-crystallins and small 
HSPs it is clear that the C-terminal domain 
is the essential conserved feature of this 
family [6]. It thus is likely that the chape-
rone properties of these proteins are pri­
marily associated with this conserved 
region, and modulated by the variable N-
terminal domain. Also the fact that the C-
terminal domain with tail can form in­
dependent orderly structures, and that this 
region is probably located at the exterior 
of the native aggregates [22], made it 
relevant to test whether these structures 
exhibit chaperone activity. Moreover, also 
in the case of HSP70, the protein-binding 
activity is associated with a separate do­
main of the protein [36]. It turned out that 
none of the three polypeptides revealed 
protection activity. Apparently, other or 
additional parts of the protein are required 
for heat protection activity. It is yet un­
clear which molecules are chaperoned by 
α-crystallin and the small HSPs in vivo 
and which protein regions are involved in 
interactions between these molecular cha-
perones and their substrates. A more 
detailed study in which the a-crystalhn 
subunits and HSP2S are less drastically 
changed, may give information about the 
elements necessary for substrate binding 
and chaperone activity. 
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Exploring the aggregation and chápenme behaviour of aA-crystallin 
by site-directed mutagenesis 

Exploring the aggregation and chápenme behaviour of aA-crystallin 
by site-directed mutagenesis 
To explore the structure and chápenme activity of a-crystallin, five point-mutants of bovine aA-crystallin 
were generated by oligonucleotide-directed mutagenesis. The mutant oA(D69S), in which an evolutionarily 
well-conserved charged residue is replaced, differed considerably from the wild-type with regard to 
secondary structure. Its heat protection capacity was substantially decreased as compared with wild-type aA-
crystallin. It appears that Asp-69 is important for stabilization of the tertiary structure, by ionic interaction, 
and that disruption of the structure leads to loss of heat protection activity. Four other mutations were aimed 
at disturbing hydrophobic intersubunit interactions. Hydrophobic residues Leu-37, Phe-39, Val-72 and Phe-
74 are predicted to be involved in contacts between subunits. They were replaced by uncharged hydrophilic 
residues. The four mutants form smaller aggregates than the wild-type, although their secondary structures 
are still intact. These mutations did not seem to significantly affect the heat protection activity. The four 
hydrophobic residues thus might indeed play a role in the interaction between subunits. 
INTRODUCTION 
or-Crystallin is a major protein component 
of the vertebrate eye lens. It is a large 
aggregate of about 800 kDa and it is com-
posed of two types of subunits, orA- and 
aB-crystallin, that occur in low amounts in 
many extralenticular tissues [1-4]. Both 
subunits have a molecular mass of about 
20 kDa and are homologous with each 
other and with the small heat shock pro-
teins (HSPs)1 [5-7]. Although hardly any 
data concerning the three-dimensional 
structure of a-crystallin and the small 
HSPs is available, gradually some aspects 
of their functions are being revealed. aB-
Crystallin is, like the small HSPs, heat-
inducible and relocates from the cytoplasm 
to the nucleus under heat shock conditions 
[8]. Both bovine a-crystallin and mouse 
HSP25 act as molecular chapetones [9-11]. 
The structures of a-crystallin and the small 
HSPs seem to be related as well [9]. 
α-Crystallin as well as the small HSPs 
exist as large aggregates [12-IS], and 
evidence has been provided that the arran­
gements of subunits resemble each other in 
both types of aggregates and that the se­
condary structures are very similar [9]. 
The common functional features of a-
crystallin and the small HSPs obviously 
relate to the structural characteristics 
shared by these proteins. Therefore, it is 
of importance to solve the three-dimensio­
nal structure of the members of this pro­
tein family. However, until now, only 
tertiary structure predictions and quaterna­
ry structure models are available. Wistow 
[16] proposed the overall structure of a-
crystallin to consist of a globular N-termi-
nal domain of two symmetry-related motifs 
and a somewhat larger C-terminal domain, 
also of two motifs, with an exposed C-ter­
minal tail. The four motifs are characte­
rized by 3 residues (Asp/GIu, Pro and 
Gly) that are well conserved, especially in 
the C-terminal domains of the a-crystal-
lin/small HSP protein family (Fig. 1). 
These residues might be of structural 
importance. One of these is Asp-69 in 
bovine aA-crystallin, which is surrounded 
by several other charged amino acid resi-
.'The abbreviations used are: HSP, heat shock protein; PMSF, phenylmethylsulfonyl chloride; DTG, 
•sopropylthio-0-D-galactoside. 
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Figure 1: Localization of the mutations in the domain structure of aA-crystallin. The structure of aA-
crystallin is displayed in five parts, the first two corresponding with the two putative motifs in the N-
terminal domain, the next two with the putative motifs in the C-terminal domain, and the last one 
representing the C-terminal extension, as proposed by Wistow [16]. The conserved aspartyl, prolyl and 
glycyl residues of potential structural importance in the four motifs are indicated. The two stretches of five 
hydrophobic residues are represented by checked boxes. In the magnified panel, these regions of aA-
crystallin and the corresponding residues of aB-crystallin are aligned to show the introduced mutations. The 
residues that are part of the five residue hydrophobic stretches in aA-crystallin are indicated with an 'A'. 
The arrows denote the mutations and the corresponding oligonucleotide numbers. 
dues (Fig. 1). It can be envisaged that salt 
bridges between these residues are impor­
tant for the stabilization of the tertiary 
structure. 
Several quaternary structure models for a-
crystallin have been proposed, including a 
three-layer arrangement [17,18], a micelle-
like conformation [19], a combination of 
these two [20] and lately a rhombo-
dodecahedric arrangement of subunits [21]. 
The nature of interaction between the 
subunits and the residues involved, are still 
unknown. 
To address the question whether Asp-69 is 
important for the structure and proper 
functioning of aA-crystallin and to find 
residues involved in intersubunit interac­
tions, five site-directed mutants of aA-
crystallin were made. Asp-69 was replaced 
by the uncharged amino acid serine. In the 
other four cases, the mutation concerned a 
single hydrophobic residue that was re­
placed by a hydrophilic, uncharged resi­
due. By means of gel permeation chroma­
tography, the effect on aggregate size was 
determined. Far UV CD spectroscopy was 
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used to analyse the correct folding into 
ordered secondary structure. The func­
tional integrity of the mutants was assessed 
on basis of this ability to protect 0L-crys-
tallin against heat denaturation. The results 
demonstrate that even in the absence of 
tertiary structure data, relevant information 
about the structural and functional roles of 
particular residues can be obtained. 
MATERIALS AND METHODS 
Bacterial strains, plasmids and reagents 
Escherichia coli strains HB101 [22] and 
JM105 [23] were used as recipients in the 
cloning experiments. Exoli TGI [24] was 
used for preparation of single-stranded 
template DNA. For overproduction of 
wild-type proteins Exoli strain В 
BL21(DE3) was used [25]. Plasmids used 
in the cloning experiments were pET8c 
[25] and pGEMZf5(+) (Promega). Res­
triction enzymes, calf intestine alkaline 
phosphatase, T4 DNA polymerase, T4 
DNA ligase and T4 polynucleotide kinase 
were purchased from Bethesda Research 
Laboratories (BRL). IPTG, ampicillin, 
chicken egg white lysozyme, DNAase and 
proteinase inhibitors were obtained from 
Sigma. Oligonucleotides were synthesized 
using a Cyclone Plus DNA synthesizer 
from Milligen/Biosearch. 
Construction of expression plasmids of 
mutant aA-crystallins 
The expression clone pETÜcaA [26], 
which contains the cDNA encoding bovine 
orA-crystallin, was used as the starting 
material for the construction of five site-
directed mutants. A 325 base pair frag-
ment, coding for residues 1-108 of 
αΑ-crystallin was obtained by Ncol-dige-
stion of pETScaA and inserted into the 
Ncol-site of pGEM5Zf(+) in such an 
orientation that the coding strand was 
replicated. The 325 base pair fragment 
was mutated according to Taylor et al. 
[27], using the oligonucleotide-directed in 
vitro mutagenesis system of Amersham. 
The five mutants were made, using the 
following non-coding oligonucleotides: 
AGGAAGGGCTGCAGTCG (1), GTGGA-
GGACAGGTTGGGCAGCAGGT (2), 
ATCCAGGAAGATGTTAAACTTGTCC-
CGG (3), CTTCACATCCAGGTTGAT-
GACAAACTTG (4) and AAGATGACAA-
ACTTAGATCTGTCGGATCGGA (5), 
resulting in the mutations L37Q, F39N, 
V72N, F74N and D69S, respectively. To 
obtain the mutant aA(V72N) the procedure 
Ncol 
^ < \ N c o l 
I рЕТВсаА I 
Ncol 
Neol 
Site-directed 
mutagenesis 
Neol 
Figure 2: Strategy for the site-directed mutage­
nesis of αΑ-crystallin. A 325 bise pair fragment 
was removed from the expression construct pET8c-
ctA by Ncol-digestion. The 325 base pair fragment 
was mutated at the desired position according to 
Taylor et cd. [27], using the five oligonucleotides 
as described in Materials and Methods. The muta­
ted fragment was then cloned back in the Ncol-
digested pETScaA vector, resulting in the construct 
pETScaA*. The asterisk indicates the présence of a 
mutation. 
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of the in vitro mutagenesis kit of Amers-
ham had to be modified. Since primer 3 
contains an Neil-site, we used Pvul in the 
nicking reaction, instead of Neil. The use 
of Pvul had no influence on the efficiency 
of the mutagenesis reaction. In all cases 
the efficiency was more than 90%. The 
mutated 325 base pair fragments were 
sequenced by the dideoxynucleotide me­
thod [28] to confirm the presence of the 
desired mutation and the absence of un­
wanted changes. The mutated 323 base 
pair fragments were then cloned back in 
the truncated expression plasmid. 
Expression and purification of wild-type 
and mutant aA-crystaUins 
The wild-type and mutated expression 
constructs were transformed in the host 
E.coli В BL21(DE3). Expression of wild-
type and mutant oA-crystallins, and prepa­
ration of the water-soluble fraction were 
performed essentially as described earlier 
[26]. Only the amount of lysozyme, used 
for the lysis of E.coli was reduced tenfold 
to 0.1 mg/ml, to limit the contamination of 
the E.coli lysate with lysozyme. The effi­
ciency of the lysis was not affected by the 
reduction of the lysozyme concentration. 
All buffers used, as well as the water for 
dialysis, contained the following additives: 
20 μΜ PMSF, 100 μΜ EDTA, 0.02 % 0-
mercaptoethanol (v/v), 40 μg/l bacitracin 
and 30 μg/l benzamidin. Lyophilized 
protein (30-100 mg) was dissolved in 
starting buffer (50 mM sodium phosphate, 
pH 6.8) and loaded on a Fast Flow 
DEAE-Sepharose column (Pharmacia-
LKB), equilibrated with starting buffer. A 
linear gradient from 50 mM to 400 mM 
sodium phosphate at pH 6.8 (2.6 mM 
phosphate/min) was used to elute the 
proteins at a linear flow rate of 
1.5 cm/min. 
Reaggregation 
Before gel permeation analysis, approxi­
mately 0.5 mg of wild-type or the mutant 
αΑ-crystallins were denatured in 4 ml of 
6 M urea for 2 h at 4°C. The denatured 
samples were then dialysed against the 
appropiate gel permeation elution buffer. 
For far UV CD spectroscopy and heat 
protection experiments, protein samples 
were refolded as follows: lyophilized 
samples were dissolved in 6 M urea and 
diluted with the appropriate buffer to a 
concentration of 1 M urea and 1 mg/ml of 
protein, dialysed against water and lyophi­
lized. All solutions used for reaggregation 
contained 0.02 % of 0-mercaptoethanoI 
(v/v) and proteinase inhibitors as indicated 
above. 
Gel permeation analysis 
Two different gel permeation columns 
were used. The Superóse 6 HR 10/30 
prepacked column (Pharmacia-LKB) was 
equilibrated with a buffer containing 50 
mM sodium phosphate (pH 7.5), 50 mM 
NaCl and 1 mM EDTA, and elution was 
performed at 0.50 ml/min. The TSK 
G4000 SWXL-column (300x7.8 mm) 
(TosoHaas), to which a guard column 
(40x7.8 mm) was coupled, was equilibra-
ted with a 150 mequiv. phosphate buffer 
(pH 6.8) [18] and eluted with a flow of 
0.80 ml/min. In both cases, samples of 
approximately 25 μg were applied and 
absorbance was monitored at 225 nm. The 
gel permeation columns were calibrated 
with the high molecular mass calibration 
kit of Pharmacia-LKB. 
Far UV circular dienroism measure­
ments 
These were performed using a Jasco Mo­
del 600 spectropolarimeter. A 0.25 mm 
pathlength cell was used. Reaggregated 
protein samples were measured in a 
50 mM phosphate buffer, pH 7.0, con­
taining 0.1 M NaCl [9]. Each spectrum 
represents an average of 4 to 16 repetitive 
scans. The α-helix content was estimated 
according to Greenfield and Fasman [29]. 
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Heat protection assay 
The capacity of wild-type and mutant aA-
crystallins to protect BL-crystallin against 
heat-induced aggregation was assayed as 
described before [10]. In all experiments 
0.16 mg of /SL-crystallin in the presence 
or absence of wild-type and mutant aA-
crystallin was dissolved in the same buffer 
as used for the CD measurements and 
centrifuged at 20,000 rpm for 20 min. The 
final volume in each experiment was 
0.4 ml. Protein concentrations were deter­
mined on basis of amino acid analysis. 
Protection against heat denaturatici! of 
0.25 mg of horse liver alcohol dehydroge­
nase (Boehringer) by wild-type and mutant 
aA-crystallins was performed at 44.3eC 
by measuring the increase in absorption at 
360 nm in triplicate. One-hundred percent 
inhibition was defined as complete protec­
tion (no change in absorbance) during an 
incubation of 45 min. 
RESULTS 
Mutagenesis of bovine aA-crystallin 
One of the goals of this study was to test 
whether the negatively charged conserved 
Asp-69 is important for the structure and 
function of bovine aA-crystallin. We 
therefore replaced Asp-69 by an uncharged 
polar residue of about the same size, 
namely serine. Additionally, we wanted to 
localize residues in the bovine aA-crystal­
lin chain that play a role in the inter-
subunit interactions in the or-crystallin 
aggregates. Hydrophobic interaction sites 
are located at the surface of the subunits. 
Because hydrophobic residues involved in 
stabilizing tertiary core interactions within 
a subunit must be strongly conserved, we 
looked for those hydrophobic residues in 
aA-crystallin that are not strictly con­
served. There are two stretches of five 
hydrophobic residues in bovine aA-crystal­
lin, residues 36-40 and 71-75. In the latter 
the second and the fourth residues are not 
conserved as hydrophobic in aB-crystallin 
(Fig. 1) and also the sequence 36-40 is not 
well conserved. These regions might be 
/9-strands that contribute to a domain core 
on one side and a domain or subunit sur­
face at the other, like the a strand in 
motifs 2 and 4 in the /9/-y-crystallins [30]. 
We replaced the second and fourth residue 
of the hydrophobic stretches by hydro-
philic, non-charged residues (Fig. 1). 
Mutations were performed as described in 
Materials and Methods and are outlined in 
Fig. 2. The mutated 325 bp fragments 
were sequenced. Those clones that con­
tained the desired mutation and did not 
have unwanted changes, were used for 
expression. 
Expression and purification of wild-type 
and mutant aA-crystallins 
Expression in E.coli and preparation of the 
water-soluble fraction of bacterial lysates 
was done as described earlier [26]. Ex­
pression levels of wild-type and mutant 
aA-crystallins were between 20 and 50%, 
A В 
0 1 2 3 4 5 6 1 2 3 4 5 6 
- ; - Щ 
Figure 3: Expression in E.coli and purification 
of wild-type and mutant aA-crystallins. Sodium 
dodecylsulfàte Polyacrylamide gel electrophoresis 
patterns of (A) the water-soluble fraction of E.coli 
BL21(DE3) overexpressing wild-type aA-crystallin 
before (lane 0) and after induction by IFTG 
(lane 1), aA-crystallin mutants 1-5 after induction 
by IFTG Ganes 2-6, respectively) and of (B) wild-
type aA-crystallin and its mutants 1-5 (lanes 1-6, 
respectively) after purification on a Fast Flow 
DEAE-Sepharose column. 
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as estimated by gel scanning (Fig. ЗА). In 
all cases the mutants were predominantly 
in the water-soluble fraction of the lysates. 
The purification of wild-type and mutant 
aA-crystallins from the water-soluble 
fraction was accomplished by ion-exchange 
chromatography on a Fast Flow DEAE 
Sepharose column in a gradient of sodium 
phosphate. A typical elution partem is 
shown in Fig. 4. The fractions were pool­
ed as indicated in Fig. 4. In this way, 
90-98% pure wild-type and mutant aA-
crystallins could be obtained (Fig. 3B). 
refolding all αΑ-crystallin variants under 
the same conditions, highly reproducible 
results could be obtained. Two different 
preparations of all mutants and the wild-
type were analysed in duplo or triplo by 
gel permeation chromatography on two 
different columns. The elution patterns of 
the αΑ-crystallin variants on the TSK 
column are shown in Fig. 5. All mutants, 
except aA(D69S) have larger elution 
volumes than the wild-type. The elution 
volumes could be measured with errors of 
Aggregate size of the mutants 
The aggregate size of wild-type and mu­
tant aA-crystallins was estimated by means 
of gel permeation chromatography on 
calibrated columns. Prior to chromato­
graphy, the purified samples were dena­
tured in 6M urea and renatured by dialysis 
against the appropriate gel permeation 
buffer. Without this reassociation step the 
elution volumes were not reproducible for 
different preparations of one mutant. By 
дь»(2ео) NlW [Ml , 
200 300 «00 
•lutlon volum· (ліЦ 
Figure 4: Elution patera of oA(F39N) on Fast 
Flow DEAE-Sepharosc Solid line: absorbance 
profile (280 nm, arbitrary units) of the water-
soluble fraction of E coli <zA(F39N). Broken line: 
phosphate gradient [M] with which the proteins 
were eluted. The arrow indicates the position of the 
mutant. The pooled fractions are indicated by the 
hatched area. Wild-type and the other mutant aA-
crystallins yielded comparable elution patterns. 
Abs(225) 
669 432 234 
Wild-type 
L37Q 
F39N 
V72N 
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D69S 
5 10 
Elution volume (ml) 
Figure 5: Gd permeation analysis of wild-type 
and mutant oA-crystallins. Absorbance profiles 
are presented after TSK G4000 SWXL chromato­
graphy of wild-type and mutant aA-crystallins. The 
first peak contains high molecular weight aggre­
gates, the second peak represents the low molecular 
weight aggregates. The position of wild-type αΑ-
crystallin is indicated by the broken line. Elution 
positions of gel permeation markers (in kDa) are 
indicated at the top of the figure. 
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less than 2%. In Table I the elution volu­
mes and corresponding molecular masses 
are presented. Clearly, the calculated 
molecular mass of aA-crystallin aggrega­
tes is strongly dependent on the type of 
column on which the analysis is carried 
out. However, the molecular mass of the 
mutants relative to that of wild-type aA-
crystallin is reproducible and not depen­
dent on the gel permeation column used. 
The mutants in which hydrophobic resi­
dues were replaced (mutants 1-4) form 
considerably smaller aggregates, indicating 
that the mutated residues are involved in 
interactions between subunits. Mutant 5 
(aA(D69S)) forms an aggregate that is 
slightly larger than that of the wild-type. 
The replacement of a conserved charged 
residue by an uncharged amino acid 
(D69S) apparently affects aggregate forma­
tion to a much lesser extent. However, the 
secondary structure of mutant 5 might be 
affected. To check whether or not the 
secondary structure of the mutants is still 
intact, we performed far UV CD experi­
ments. Additionally, a 'chaperone assay' 
was carried out to assess the maintenance 
of functional activity. 
Far UV CD spectroscopy 
In Fig. 6 the far UV CD spectra of all five 
mutants compared with wild-type aA-
crystallin are shown. Only the spectra of 
aA(V72N) and aA(F74N) are identical to 
that of wild-type aA-crystallin (panels С 
and D, respectively). The far UV CD 
spectrum of aA(F39N) slightly differs 
from that of the wild-type, its minimum 
being shifted to a somewhat lower wave­
length (panel B). The spectrum of 
aA(L37Q) is different from that of wild-
type (panel A). Its -218 nm minimum is 
shifted to a higher wavelength and some 
intensity is lost at -208 nm, indicating 
that the α-helix content might even be 
lower than in the wild-type. However, the 
secondary structure in mutants 1-4 is 
mainly j3-sheet, with a maximum of 10% 
of α-helix, which is normal for aA-crys­
tallin. In contrast, the CD spectrum of 
aA(D69S) is dramatically different from 
that of wild-type aA-crystallin. The pro­
nounced minimum at -208 nm indicates 
that aA(D69S) contains a considerable 
amount of α-helix (up to -30%). The 
mutation D69S clearly affects the seconda­
ry structure, indicating that this charged 
residue (Asp-69) is important for retaining 
the proper structure of aA-crystallin. 
Table I: Elution volumes and molecular masses of wild-type and mutant 
aA-crystallin. 
wt. 
L37Q 
F39N 
V72N 
F74N 
D69S 
Superóse 6B 
Ve (ml) 
12.45 
12.80 
13.21 
12.97 
13.02 
12.29 
Mol. mass 
(kDa) 
580 
510 (-12%)f 
430 (-26%) 
470 (-19%) 
470 (-19%) 
620 (+7%) 
TSK G4000SWXL 
Ve (ml) 
9.04 
9.25 
9.52 
9.37 
9.30 
8.89 
Mol.mass 
(kDa) 
690 
600 (-13%) 
510 (-26%) 
560 (-19%) 
580 (-16%) 
750 (+8%) 
* Between brackets the change of the aggregate size relative to that of wild-type orA-ciystaüin 
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Inhibition of thermal aggregation of ßL-
crystallin by wild-type and mutant oA-
crystallins. 
Recently, α-crystallin was shown to act as 
a molecular chaperone in vitro. /SL-Crys-
tallin and other proteins are effectively 
protected against heat-induced denaturation 
in the presence of α-crystallin or the aA-
and aB-homopolymers [10]. To determine 
whether the αΑ-mutants are as efficient in 
protecting j9L-crystallin as wild-type orA-
crystallin, the following experiment was 
carried out. A solution containing 0.16 mg 
of ßL-oystallin in 0.4 ml was heated in 
the absence or presence of wild-type or 
mutant orA-crystallins. To be able to detect 
differences in heat protection capacity, the 
assay was carried out with low amounts of 
αΑ-crystallin, so that 0L-crystallin is not 
fully protected. A molar ratio of approxi­
mately 1:100 of αΑ-crystallin to /SL-crys-
tallin, based on molecular masses of 600 
and 60 kDa, respectively, was used in the 
assay. However, it turned out that at low 
concentrations of αΑ-crystallin to j3L, the 
system is extremely sensitive, and someti­
mes a change of 1°C or less, or very 
small differences in the protein concentra­
tion have dramatic effects on the kinetics 
of aggregation. Therefore, it is not possi­
ble to detect minor differences in heat 
protection activity between the mutants. In 
Fig. 7 the heat protection curves for equal 
weights of wild-type or mutant aA-crystal-
lins (0.016 mg) are depicted. It is striking 
that aA(D69S) (Fig. 7E) is very inefficient 
in protecting 0L-crystallin against heat, 
compared to the wild-type and other mu­
tants. In Fig. 7F are the heat denaturation 
curves when larger amounts of aA(D69S) 
are added. Only at higher concentrations, 
this mutant exhibits some heat protection 
activity. A three to four times higher 
concentration of aA(D69S) is needed to 
achieve approximately the same heat pro­
tection activity as, for example, aA(V72N) 
(Fig. 7C). To provide additional evidence 
that aA(D69S) is less active indeed, the 
heat-protective capacity of wild-type αΑ-
crystallin and several mutants, including 
aA(D69S) was compared in another expe­
riment. Various amounts of wild-type and 
mutant αΑ-crystallins were tested for their 
ability to protect alcohol dehydrogenase 
against denaturation at 44.3°C (Materials 
and Methods). 0.S /tg of wild-type and 
mutant αΑ-crystallin were able to inhibit 
heat denaturation of alcohol dehydrogenase 
for 40%. 0.5 μ% of aA(D69S), however, 
resulted in only 10% protection activity. 
2 μg of aA(D69S) was needed to achieve 
40% protection. Also aA(F39N) was 
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Figure 6: Far UV CD spectra of wild-type and mutant αΑ-crystallins. Panels A-Ε represent CD spectra 
of mntints 1-5 (solid lines), respectively, in comparison with the CD spectrum of wild-type αΑ-crystallin 
(broken lines). All CD spectra are normalized to a protein concentration of 0.5 mg/ml. The optical 
pathlength was 0.25 mm. The spectra are the average of 4 to 16 repetitive scans. 
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found to be less active with regard to heat 
protection (Fig. 7B). However 0.5 /ig of 
this mutant resulted in 40% of heat protec­
tive capacity, like the wild-type and other 
mutants. 
DISCUSSION 
Despite the efforts that have been made to 
solve the structure of α-crystallin, little is 
known yet about its native conformation. 
Until now, it has not been possible to 
crystallize α-crystallin. Charge hetero­
geneity, brought about by the various post-
translational modifications, might be one 
of the reasons for this problem p i ] . An­
other possible cause is the dynamic and 
flexible nature of the α-crystallin ag­
gregate [19,32]. To get information about 
the tertiary and quaternary structure of 
α-crystallin, indirect methods have been 
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Figure 7: Heat-induced aggregation of tfL-crystallin in the absence and presence of wild-type or 
mutant aA-crystallins. In each experiment 0.16 mg of j9L-crysta]lin and 0.016 mg of wild-type or mutant 
αΑ-cryetallins was used, unless indiralfd otherwise. The beating temperature was not identical for all 
mutants and is indicated in the Figure Heat protection capacity of aA-crystalun mutants (mutant 1-5, curvea 
3 m panels A-E, respectively) is compared with that of wild-type aA-crystalun (curves 2). Curves 1 
represent aggregation of BL-cryetallin alone. Curve 4 in panel В represents the beat protection curve 
obtained when 0 02 mg of orA(F39N) is used. Panel F compares the heat protection capacity of increasing 
amounts of the mutant crA(D69S): 0.04 mg for curve 3 and 0 06 mg for curve 4. 
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employed, in which a-crystallin is modi­
fied and the effect on the structure mea­
sured. Many possibilities have been tested 
like sulphydryl and citraconic anhydride 
modification [33,34], and iodination of 
surface residues [35]. Site-directed muta­
genesis is nowadays often used to obtain 
protein structure information, but had 
hitherto not been applied to a-crystallin. 
We now designed five site-directed mu­
tants of bovine crA crystallin and measured 
the effect of the mutations on aggregate 
size, secondary structure and heat protec­
tion activity. Two kinds of mutants were 
made: one mutation concerned the replace­
ment of a charged residue by an uncharged 
one, and another four mutants were re­
placements of hydrophobic by hydrophilic 
amino acids. 
Electrostatic interactions are important for 
protein structure and function [e.g. 36-39]. 
The maintenance of a proper distribution 
of charged amino acid residues might 
therefore be an important factor in protein 
evolution. Leunissen et al. noticed that eye 
lens crystallins, and in particular a-crystal­
lin, avoid changes in charge [40]. Indeed, 
charged interactions between the eye lens 
crystallins are supposed to be of extreme 
importance to maintain the transparency of 
the lens fiber cells. A close and even 
packing of these proteins is required to 
prevent light scattering [41,42]. By com­
paring the protein sequences of a-crystal-
lins and small HSPs, it can be observed 
that certain charged residues are conserved 
throughout the protein family and in both 
protein domains (Fig. 1) [5]. One of these 
charged residues is aspartic acid at posi­
tion 69 in bovine αΑ-crystallin, which is 
surrounded by pairs of oppositely charged 
residues (Fig. 1). Ion pairs at the surface 
of proteins are known to stabilize the 
tertiary structure and contribute to the 
thermostability of proteins [39,43,44]. It is 
therefore conceivable that Asp-69 is invol­
ved in stabilizing the tertiary structure. 
This aspartic acid residue was substituted 
by serine. UV CD spectroscopy esta­
blished that aA(D69S) contains secondary 
structure elements, but the spectrum is 
quite different from that of wild-type αΑ-
crystallin. The α-helix content is much 
higher in aA(D69S). Remarkably, despite 
the alteration in secondary structure, the 
quaternary structure does not seem to be 
affected. aA(D69S) still forms large ag­
gregates, slightly larger than those of wild-
type αΑ-crystallin. In fact, the viability of 
the structure is not grossly disrupted by 
this mutation, since aA(D69S) is still 
water-soluble. 
The heat protection activity of aA(D69S) 
is considerably lower than that of the wild-
type. Several possible reasons for the 
decreased protection capacity can be envi­
saged. The alteration of secondary structu­
re elements, necessary for the binding to 
/3L-crystallin (the stressed protein), might 
cause the observed decrease in heat protec­
tion activity. It might also be the negative 
charge itself that is important for the 
interaction of a-crystallin with /3L-crystal-
lin. Charged residues are mostly found on 
the surface of proteins and may be of 
importance for recognition and interactions 
between molecules [45,46], for instance 
the interaction of a-crystallin with cytoske-
letal proteins [47-50]. Our results clearly 
demonstrate that Asp-69 is important for 
the structure and function of αΑ-crystallin. 
The other four mutants replace hydropho­
bic residues by hydrophilic ones. The sites 
that form the protein interior are occupied 
mainly by nonpolar residues. The surfaces 
between secondary structure elements are 
almost entirely hydrophobic in character 
[51]. On the other hand, hydrophilic surfa­
ces are almost always accessible to the 
solvent. Residues that are involved in 
aggregate formation, thus in intersubunit 
interactions, are not expected to form part 
of the hydrophobic core, but are present 
on the surface of a subunit. However, they 
should not be exposed to the solvent. 
Evolutionarily well conserved hydrophobic 
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residues are likely to form part of the 
hydrophobic core, whereas less conserved 
hydrophobic residues could be present at 
the subunit interface. Four hydrophobic 
residues of αΑ-crystallin, not conserved as 
hydrophobic in aB-crystallin and making 
part of a hydrophobic five-residue stretch, 
were chosen to be replaced by polar but 
uncharged residues. All four mutants differ 
from wild-type αΑ-crystallin by forming 
smaller aggregates, up to 26% smaller 
than the wild-type aggregate. These muta­
tions had little or no effect on the seconda­
ry structure. In all four cases the seconda­
ry structure is primarily /3-sheet, like in 
αΑ-crystallin. Also the chaperone activity 
is largely retained in the mutants 1-4. The 
conclusion we may draw from this study is 
that the replacements of L37, F39, V72 
and F74 by glutamine or asparagine do not 
change the secondary structure and have 
no drastic effects on the chaperone ac­
tivity. The aggregate size, however, is 
affected; all four mutants form considera­
bly smaller aggregates than the wild-type. 
It thus may be that the above mentioned 
hydrophobic residues form part of interac­
ting hydrophobic subunit surfaces. 
An increased knowledge of the structure of 
members of the a-crystallin/small HSP 
family would contribute to a better under­
standing of their in vivo function. It is still 
unclear which molecules are chaperoned 
by a-crystallin and the small HSPs in vivo, 
under which circumstances and by what 
mechanisms. In contrast with members of 
the chaperonin 60 family, and the HSP70 
and 90 families [S2-SS], a-crystallin and 
HSP2S do not seem to require ATP to 
refold γ-crystallin or protect /3L-crystallin, 
citrate synthase and a-glucosidase [9-11]. 
It is therefore particularly interesting to 
unravel the structure-function relationship 
of the α-crystallin/small HSP family. 
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CHAPTER 6 
Characterization of anti-crystallin autoantibodies 
in patients with cataract 

Characterization of anti-crystallin autoantibodies 
in patients with cataract 
Anb-crystallin autoantibodies have often been demonstrated in the serum of healthy penóos and, especially, 
patients with cataract. In no case, however, have the specific crystallin subunits been identified against 
which such antibodies are directed. This information would be of particular interest in view of the recent 
finding that several crystallin subunits occur constitubvely outside the lens. To fill this gap, we analysed the 
sera of 15 patients with mature cataract by means of 1- and 2-dunensional unmunoblotting. The circulating 
antibodies turned out to be directed against several B- and γ-crystalun subunits. The types of subunits and 
the intensities of the responses varied considerably between patients. No or only occasional and very weak 
reactions were observed against the a A-, aB- and BB2-crystallin subunits. These are in fact the only 
crystalline at present known to occur outside the lens in mammals. Our findings thus indicate that anb-
crystallin autoantibodies are specifically directed against those crystallms that appear to be lens-restricted, 
while immunological tolerance would exist for the extra-lenbcularry occurring crystalline. 
INTRODUCTION 
The eye lens crystallins have always been 
considered as organ-specific proteins par 
excellence. Studies of the causes and ef­
fects of autoantibodies against the crystal­
lins were therefore undertaken and inter­
preted from this perspective. However, the 
notion of lens-specificity of the crystallins 
has drastically changed since the recent 
findings of extra-lenticular crystallins [e.g. 
1-3]. There have been earlier indications 
that crystallins may occur in trace amounts 
in ocular tissues other than the lens [4]. 
This was often attributed to the fact that 
the lens capsule, especially in cataract, is 
not a perfect barrier for proteins [5, 6]. It 
now appears that in many species certain 
crystallins occur constitutively outside the 
lens [7,8]. In man and other mammals orB-
crystallin is quite abundant in many tis­
sues, notably in heart, striated muscle and 
kidney [1, 9]. Recently the presence of 
very low amounts of extra-ocular aA-crys-
tallin has been demonstrated, most clearly 
in rat spleen and thymus [2]. Also /9B2-
crystallin has now definitely been shown to 
occur outside the lens in rat and cat (M. 
W. Head and R. M. Clayton, personal 
communication). 
In the light of these findings the pheno­
menon of circulating autoantibodies against 
crystallins comes into a different context. 
The presence of anti-crystallin antibodies 
in up to about 50% of normal human sera 
has been reported in several studies [10-
13], although not in others [14-17]. This 
no longer requires the assumption of lea­
kage of crystallins from the lens to get in 
contact with the immune system. Increased 
levels of anti-lens antibodies in cataractous 
patients are usually reported [11-13, 16], 
although not always [17]. Again, the in­
creased leakage of crystallins from catarac­
tous lenses needs no longer to be as­
sociated with an autoimmune response 
against all crystallin subunits, because 
tolerance against the extra-lenticular crys­
tallins may exist. 
No studies have been published in which 
the specific crystallin subunits reacting 
with anti-lens autoantibodies have been 
characterized. Such a study can best be 
performed on sera of patients with mature 
cataract, where the immune system is 
likely to be exposed for long periods to 
crystallins leaking out of the lens. It 
should then reveal whether or not a partem 
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can be discerned in which certain crystal-
lin subunits are more autoimmunogenic 
than others. A more pronounced autoim­
mune response would be expected against 
crystallin subunits that do not normally 
occur outside the lens. To make an initial 
inventory of anti-crystallin autoantibodies 
we here report the characterization of IS 
patient sera by one- and two-dimensional 
immunoblotting. Our results demonstrate 
that great individual variation exists in the 
autoimmune response against crystaUins. 
Antibodies against most β- and γ-crystallin 
subunits were frequently found, while no 
or hardly any antibodies against aA, aB­
and ßB2-crystallin could be observed in 
this limited sample. 
MATERIALS AND METHODS 
Blood was obtained from 10 patients suf-
fering from senile and presenile mature 
cataract, and from 5 patients with luxated 
lenses and secondary mature cataract. 
Blood from 3 persons without ophthal-
mological problems was used for controls. 
The blood was allowed to clot and the 
serum collected by centrifugation at 4°C. 
The sera were then stored at -20"С until 
use. 
One-dimensional Polyacrylamide gel elec­
trophoresis (ID SDS-PAGE) of lens pro­
teins was performed according to Laemmli 
[18]. Two-dimensional Polyacrylamide gel 
electrophoresis (2D SDS-PAGE) was 
performed as described by O'Farell [19]. 
The isofocusing gels contained ampholines 
(LKB, Uppsala, Sweden) in the pH ranges 
6-8, 7-9 and 3Ά-10, mixed in a ratio of 
3:3:10. The ID gels, used for Western 
blotting, were loaded with total water-
soluble lens proteins of calf or human fetal 
lens (23 μg per cm of gel), or with 0.S μg 
per cm of gel of aA-, aB-, 0B1- and /3B2-
crystallin each. The latter subunits were 
isolated from calf lenses according to de 
Jong et a!. [20] and Berbers et al. [21]. 
2D gels were loaded with 40 μ% or ISO /ig 
of the water-soluble fraction of either calf 
lenses (6 months) or fetal human lenses 
(130-200 days) for Western blotting and 
Coomassie Brilliant Blue (CBB) staining, 
respectively. 
For Western blotting the proteins were 
transferred from the gel onto nitrocel­
lulose, according to Towbin et al. [22]. 
Incubations of the nitrocellulose blots with 
the sera and the washing step just before 
the staining reaction were carried out 
overnight, to minimize aspecifíc reactions. 
Human sera were diluted hundred-fold 
before incubation. Peroxidase-conjugated 
goat anti-human immunoglobulin (Nordic, 
Tilburg, The Netherlands) was used as 
second antibody against the human im-
munoglobulins at a dilution of 1:1000 and 
in the presence of 0.5% BS A. The control 
antisera used were prepared in rabbits 
against bovine aA2 and aB2 (polyclonal, 
dilution 1:2000), bovine j9Bl (polyclonal, 
dilution 1:500, [23]) and bovine 0B2 
(polyclonal, dilution 1:2000, provided by 
Dr. J. Horwitz, UCLA). As second an-
tibodies against the control antibody, 
peroxidase-conjugated swine anti-rabbit 
immunoglobulin (Dakopatts, Denmark) 
was used at a dilution of 1:250 in the 
presence of 1% normal goat serum. Im-
munostained Western blots were post-
stained with Ponceau S to identify the 
immunoreactive spots. 
RESULTS 
In order to get an initial idea of the titers 
and types of the anti-crystallin antibodies 
in the sera of cataract patients and in 
normal control sera, we performed Wes-
tern blotting on total water-soluble calf and 
fetal human lens proteins, resolved by ID 
SDS-PAGE. The sera of IS patients and 
three controls were screened. The patient 
antisera consistently showed a stronger 
reaction than the controls, where only very 
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weak bands could be observed. Also 
among the patients the patterns and inten­
sities of the reaction varied considerably 
(data not shown). These one-dimensional 
patterns do not distinguish between the 
specific crystallin subunits to which the 
antibodies in the sera are directed. To 
identify these subunits we had to resort to 
Western blots after 2D SDS-PAGE of calf 
lens proteins. The positions of the different 
calf lens crystallin polypeptides on 2D 
SDS-PAA gels are better known [24] than 
those of human. In order to identify the 
crystallin chains to which the antibodies 
are directed we selected б patient sera, 
which exhibited the strongest and most 
variable reaction on ID immunoblots, to 
incubate 2D Western blots. The blots were 
stained until a clear partem was obtained 
(Fig. 1, panels A2-7). The spots on the 
Western blots were identified by staining 
with Ponceau S, and by comparing the 
Ponceau S pattern with the corresponding 
CBB-stained gel (Fig. 1, panel Al). The 
results are summarized in Table I. The 
relative intensities of the spots of all iden­
tified crystallin chains are given, as well 
as those for three unknown protein com­
ponents, indicated as 1, 2 and 3. Since the 
staining times were different for all blots, 
the intensities of spots on the different 
blots cannot be compared with each other, 
whereas spots on the same blot can. From 
the blots and from the table, one can see 
that there are great differences between the 
reaction patterns of the different sera. 
More or less strongly reacting in all six 
sera are BAI, β A4 and y&. Most others, 
like ВАЗ, у and #2, are reacting in most 
but not all sera. Strikingly, none of the 
sera reacts with calf aA-, aB- and 0B2-
crystallin. This could in principle be due 
to differences between calf- and human 
crystallin sequences, although the polypep­
tides of human crystallins resemble very 
much the corresponding bovine ones. It 
would therefore be of interest to analyse 
the reaction of the antisera with the auto-
Table I:: Relative intensities of spots on 
calf lens immunoblots after treatment with 
human sera from patients with mature 
cataract.* 
Fig. 1 2 3 4 5 6 7 
Patient nr. 8 9 10 11 14 15 
aA 
aB 
/SAI 
0A2 
β A3 
0A4 
jSBl 
0B2 
/3B3 
Ί 
yS* 
1 
2 
3 
+ 
± 
+ 
+ 
± 
± 
+ 
+ 
-
-
-
+ 
-
-
+ 
± 
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
+ 
-
-
-
± 
-
-
-
+ 
-
+ 
+ 
± 
± 
+ 
+ 
± 
+ 
+ 
+ 
-
± 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
* - no reaction, ± weak reaction, + clear reaction, 
-I- + strong reaction. 
f
 formerly j9s 
logous, human crystallins, even though 
most of these are not identified on the 2D 
SDS-PAA gel pattern. However, the posi­
tions of human aA, aB and /3B2 could 
easily be determined by immunostaining 
with specific antisera (Fig. 1, panel B). 
Blots, of the water-soluble fraction of fetal 
human lenses, resolved by 2D SDS-PAGE, 
were incubated with the six patient sera 
and stained until a clear pattern was ob­
tained (Fig. 1, panels B2-7). To identify 
the immunoreacting crystallin chains, the 
blots were stained with Ponceau S. Only in 
one case (patient 9) a relatively weak 
reaction with aA could be observed. A 
very weak reaction with аВ-crystaüin was 
observed with the serum of patient 8. To 
ascertain the position of aB, the blots were 
post-stained with the polyclonal antibody 
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Fig. 1: Identification of crystallin subunits reacting with s o « from cataract patients. 2D SDS-PAGE 
patterns (1) and their corresponding inununoblots (2-7), of the water-soluble proteins of calf lens (panel A) 
and of fetal human lens (panel B). The SDS-PAA gels (1) are stained with CBB. The corresponding 
immunoblots (2-7) were incubated with patient sera 8, 9, 10, 11, 14 and 15, respectively, and stained as 
described in Materials and Methods. On the CBB-stained patterns, the names of the bovine crystallin 
submits are indicated [24]. The numbers 1, 2 and 3 indicate unidentified bovine crystallin subunits. BB2, 
ВАЗ and В A4 have minor charge forms. The positions of especially BB1 and γ may vaiy considerably on 
different blots. The relative position of γβ on the blots is somewhat higher than on the CBB-stained gel. The 
human aA2, oB2 and BB2 are identified by specific antisera, and the γ'β are indiralfrl on basis of their 
charge. The human BB1 polypeptides are very basic and therefore not present on the 2D-gels. On the 
immunoblots, reacting subunits are indicated by lines, which are oriented in accordance with the pattern on 
the corresponding CBB-stained gel. 
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Fig. 1: Continued 
spot appeared at a position where no prior 
staining with the human sera was obser­
ved. Finally, in no case a reaction with 
0B2 was found. 
To confirm that autoantibodies against 
aA-, oB- and 0B2-crystallin are absent or 
scarce in patient sera, we should have 
performed 2D blotting on the other 9 
samples. Since this is quite laborious, and 
because not always enough serum was 
available, we obtained the desired infor­
mation from ID Western blots. These 
blots, containing a mixture of crA-, aB­
and /?B2-crystallin from calf lenses, were 
incubated with all IS sera. As an internal 
positive control, 0Bl-crystallin, with 
which many of the sera react, was also 
present in the crystallin mixture. In Fig. 2 
the results are presented. A clear reaction 
with the jSBl-subunits is observed. In none 
of the cases a reaction, with aA occurs, 
except for patients 9 and 12, which exhibit 
a very weak response. Only in the case of 
patient 8, a very weak reaction with oB 
was visible on the blot. However, the 
reaction was so weak that it could not be 
reproduced on the photograph. In some 
cases (patients S, 7 and 10) a very weak 
reaction with a protein at the position of 
j9B2-crystallin is observed. This is not in 
agreement with the clear results obtained 
from the 2D Western blotting experiment, 
where never a reaction with /3B2 was seen. 
It was found that a minor contamination 
was present in the /3B2-crystallin fraction, 
as judged by denaturing iso-electrofocus-
ing. The reacting antibodies most probably 
are directed against this contamination. 
The screening of these IS sera thus seems 
to indicate that, in general, no antibodies 
against aA-, aB-, and 0B2-crystallin are 
present in sera of cataract patients. 
There are some remarkable features in our 
results. The intensities of the different 
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Fig 2: Reaction of specific crystallin subunits (aA, oB, BB2 and ABI) with sera of cataract patients. 
Western blot strips, containing approximately equal amounts of bovine aA-, oB-, BB2- and BBl-crystallin, 
wen incubated with the sen of all cataract patients. Lane a shows the CBB-stamed pattern of the crystallin 
munire, lanes b-e show Western blot strips incubated with anueera against BB1, BB2, oB and aA, 
respectively. Lanes 1-15 show the Western blot strips incubated with the sera of cataract patients with the 
corresponding number. 
spots stained by a particular serum, while 
perfectly reproducible, do often not cor­
relate well in the 2D patterns of calf and 
human lens proteins. For instance, a y-
crystallin spot is clearly present on the blot 
of human crystallins with serum 11, but 
not detectable on the calf lens blot (panels 
BS vs. AS). Likewise, αΑ-crystallin reacts 
with serum 9 on the human blot, but is not 
detectable on the calf blot (panels B3 vs. 
A3). Remarkable, too, is the fact that on 
the calf blots the reaction with BAI is 
always more pronounced than the reaction 
with ВАЗ. This is unexpected since ВАЗ is 
in fact the same polypeptide as BAI, only 
having IS N-terminal residues extra [25]. 
It can be envisaged that the antibodies 
present in the sera are primarily directed 
against an epitope containing the free N-
terminus of BAl-crystallin. This epitope 
would be altered by the N-terminal exten­
sion of ВАЗ-crystallin, making it less 
reactive. 
DISCUSSION 
In mature cataracts longstanding leakage of 
crystallins through the damaged capsule is 
likely to occur. The immune system is 
thus exposed to the crystallins which are 
normally sequestered in the lens. How­
ever, those crystallins that normally occur 
in small amounts outside the lens would be 
recognized as self, and therefore not nor­
mally evoke an autoimmune response. 
Only the truly lens-specific crystallins 
would be reacted against as non-self, thus 
triggering the formation of autoantibodies. 
Among our IS sera of patients with mature 
cataracts there were no or only rare and 
weak reactions against aA-, aB- and BB2-
crystallins. It is striking that these proteins 
are precisely the only crystallins hitherto 
demonstrated to occur extra-lenticularly in 
mammals [1-3]. The absence of autoan­
tibodies against these crystallins is in 
perfect agreement with the prediction that 
an autoimmune response would not nor­
mally be expected against crystallins that 
occur constitutively outside the lens. 
In mammals no other crystallins than aA, 
aB and BB2 have yet been observed out­
side the lens, although in chicken the BB2 
and ВАЗ/Al crystallin mRNAs occur in 
the retina [3]. It is of course still possible 
that additional crystallins will tum out to 
be extra-lenticular in human. From an 
evolutionary point of view it is surprising 
that at least y& and one or more of the 
other 7-crystallins have not been found 
outside the lens. The divergence of the B-
and γ-crystallins probably proceeded the 
origin of the vertebrate eye [25]. Not only 
an ancestral B-crystallin, but also the 
original γ-crystallins should therefore ini­
tially have had an extra-lenticular function, 
which might be expected to still be main-
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tained in present-day vertebrates. How-
ever, considering the frequent and rela-
tively pronounced autoimmune response 
against all -y-crystallins and almost all B-
crystalins in the patients tested, it appears 
that they are approached as if they are 
non-self. This indicates that these crystal-
line have not been in contact with the 
immune system at any time during deve-
lopment, and thus are most likely confined 
to the lens. 
In several studies it has been reported that 
antì-crystallin antibodies are present in up 
to about 50% of normal human sera [ΙΟ­
Ι 3]. In sera of healthy control patients we 
could also detect autoantibodies, although 
the reactions were less intense as com­
pared with patients suffering from cataract. 
We also observed an increase in intensity, 
with increasing age of the healthy controls. 
It should be noted that considerable vari­
ation exists in the types and intensities of 
autoantibodies in different patients. Some 
crystallins, evoke strong responses in some 
patients, but not in others (e.g. protein #2, 
ВАЗ). This is not too surprising in view of 
the poorly understood and seemingly 
capricious nature of the human autoim­
mune response in general. It should finally 
be mentioned that antibodies to e-crystallin 
have transiently been detected, by radioim­
munoassay, in mice after lens rupture by 
needling [26]. Antibodies against cr-crys-
tallin, as well as β- and γ-crystallins, were 
also reported, as determined by im-
munoblotting and enzyme-linked im­
munosorbent assay, in normal sera and at 
increased level in patients with senile 
cataract [27]. Whether these reports are 
really conflicting with our findings, or 
rather can be explained by differences in 
experimental approach, requires further 
study. 
REFERENCES 
1. Bhat S.P. lud Nagineni C.N. (1989) Biochem. 
Biophys. Res. Commun. 158, 319-325. 
2. Kato К., Shinofaai* H., Kurobe N.. Goto S., 
Inaguma Y. and Oshima K. (1991) Biochim. 
Biophys. Acta 1080, 173-180. 
3. Head M.W., Peter A. and Clayton R.M. 
(1991) Differentiation 48, 147-156. 
4. Clayton R.M., Campbell J.C. and Truman 
D.E.S. (1968) Exp.Eye Res. 7, 11-29. 
5. François J. and Rabaey M. (1958) Acta Oph-
thalmol. 36, 837-844. 
6. Fisher R.F. (1978) Inlerdiscipl. Topica Gerant. 
13, 131-142. 
7. Wistow G.J. and Puuigonky J. (1988) Annu. 
Rev. Biochem. 57, 479-504. 
8. Piatigprsky J. and Wistow G. (1991) Science 
252, 1078-1079. 
9. Iwala T., Kume-Iwala Α., Liem R.K. and 
Goldman J.E. (1989) Cell 57, 71-78. 
10. Hackett E. and Thompson A. (1964) Lancet 2, 
663-666. 
11. Sandberg И.О. and Close O. (1979) Scand. J. 
Immunol. 10, 549-554. 
12. Angunawela I. (1987) Immunology 61, 363-
368. 
13. Nissen S.H., Andersen P. and Andersen 
H.M.K. (1981) Br. J. Ophthalmol. 65, 63-66. 
14. Deschtaes J., Barnes M. and Anteka A. (1989) 
Invest Ophthalmol. Vis. Sci. 30, 83, ARVO 
abstracts. 
15. Luntz M.H. (1968) Exp. Eye Res. 7. 561-
569. 
16. Paid M., Shine B. and Murray P.I. (1990) 
Int. Ophthalmol. 14, 97-100. 
17. Wirostko E. and Spalter H.F. (1967) Arch. 
Ophthalmol. 78, 1-7. 
18. Laemmli U.K. (1970) Nature 227, 680-687. 
19. O'FareU P.H. (1975) J. Biol. Chem. 250, 
4007-4021. 
20. de Jong W.W., Zweers Α., Versteeg M. and 
Nuy-Terwindt E.C. (1984) Eur. J. Biochem. 
141, 131-140. 
21. Berbers G.A.M., Boerman O.C., Bloemendal 
H. and de Jong W.W. (1982) Eur. J. Bio­
chem. 128, 495-502. 
22. Towbin H., Staehelin T. and Gordon J. (1979) 
Proc. Nad. Acad. Sci. U.S.A. 76, 4350-4354. 
23. Mulders J.W.M., Hoekman W.A., Bloemendal 
H. and de Jong W.W. (1987) Exp. Cell Res. 
171, 296-305. 
98 CHAPTER б 
24. Berbers G.A.M., Fcenstra R.W., vin den Bos 
R., Hoekman W.A., Bloemendal H. and de 
Jong W.W. (1984) Proa Natl. Acad. Sci. 
U.S.A. 81. 7071-7020. 
25. Berbere G.A.M., Hoekman W.A., Bloemendal 
H., de Jong W.W., Kleinschmidt T. and Brau-
nitzer G. (1984) Eur. J. Biochem. 46, 467-479 
26. Goldschmidt L., Goldbaum M., Walker S.M. 
and Weigle W.O. (1982) J. Immunol. 129, 
1652-1657. 
27. Ohga H, Katayama T, Egi К end Fujiwara H 
(1990) In: Usui M, Ohno S and Aoki K, (Eds) 
Ocular Immunology Today: Proceedings of the 
5th international symposium on the immunol­
ogy and immunopathology of the eye, Tokyo 
13-15 March 1990 (pp 391-394) Elsevier 
Science Publishers, Amsterdam. 
SUMMARY/SAMENVATTING 

SUMMARY 
To better understand how the eye lens refracts the incident light and how it is organized 
to yield a perfectly transparent tissue, it is of importance to know the structures of its 
composing elements. The major protein components of the eye lens are the crystallina, of 
which α-crystallin is the most abundant class in many vertebrates. a-Crystallin occurs as 
a large aggregate, composed of two types of subunits, orA- and aB-crystallin. The 
elucidation of the spatial conformation of α-crystallin becomes increasingly interesting 
considering the discoveries made during the last ten years. α-Crystallin was found to 
belong to the same protein family as the ubiquitous small heat shock proteins (HSPs), 
which are thought to play a crucial role in the survival of organisms under conditions of 
stress. Additionally, both subunits of α-crystallin occur in different cell types outside the 
lens. The expression of aB-crystallin is associated with various stress conditions and 
occurs at elevated levels in several diseased tissues. Moreover, it has recently been shown 
that α-crystallin can act as a molecular chápenme in vitro. The elucidation of the three-
dimensional structure of α-crystallin might thus contribute to a better understanding of the 
function of the members of the α-crystallin/small HSP family. 
It is likely that the common property of the a-crystallins and the small HSPs to form 
large aggregates is essential for their function. This thesis therefore focuses on the 
quaternary structure of α-crystallin. Additionally, it illustrates the structural and functio­
nal relationship between α-crystallin and mammalian small HSP. 
In chapter 2 a study is described in which the mouse small HSP (HSP25) is compared 
with α-crystallin, with respect to several known properties of the latter, to extend the 
insight into their structural and functional similarities. One of the properties of a-
crystallin is its ability to function as a molecular chaperone. Chaperones are proteins that 
prevent the formation of incorrect structures or interactions of other proteins and that 
unscramble any that do occur, as might result from heat shock or other forms of stress. It 
is shown that, like α-crystallin, HSP25 can function as a molecular chaperone, being able 
to prevent the heat-induced denaturation of 0L-crystallin. HSP2S also is an efficient 
inhibitor of elastase and is found to be a substrate for tissue-type transglutaminase, like 
aB-crystallin. It is envisaged that α-crystallin and HSP2S might have similar structures, 
since they resemble each other in secondary structure, are equally stable towards dis­
sociation by urea treatment and form viable mixed aggregates from any combination of 
subunits. 
The α-crystallin and small HSP subunits are presumably composed of two globular 
domains and an extending C-terminal tail (chapter 1, ref. 30). It has been proposed that 
the C-terminal domain, which is the best conserved sequence within the a-crystallin/small 
HSP protein family, is the 'aggregation domain'. To test this hypothesis the N-terminal 
domain and C-terminal domain, including the flexible tail of αΑ-crystallin were isolated 
and tested for their ability to form aggregates. This study is described in chapter 3. It 
turned out that the C-terminal domain and tail (aA2Dt) forms dimers or tetramers, 
whereas the N-terminal domain exists in a less-defined high molecular weight multimene 
form. To further explore the importance of the conserved C-terminal domain and tail, the 
corresponding protein fragments of aB-crystallin (aB2Dt) and HSP25 (HSP2Dt) were 
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isolated and investigated with regard to secondary and quaternary structure (Chapter 4). 
aA2Dt, aB2Dt and HSP2Dt have secondary structure elements that closely resemble 
those of the proteins from which they are derived, namely mainly 0-pleated sheet 
structure and hardly any α-helical structure. This is in agreement with the proposal that 
the or-crystallin/small HSP subunits are composed of two domains with similar structural 
motifs. Besides, like their primary structures, their secondary structures are conserved. 
aB2Dt and HSP2Dt form large aggregates, which seems to be in contrast with the 
aggregation behaviour of aA2Dt. However, they are most probably composed of dimeric 
or tetrameric building blocks. The results were therefore taken to fit the rhombo-
dodecahedric model for the quaternary structure of a-crystallin and the small HSPs 
(chapter 1, ref. 139). 
In chapter 5, the effect of several point-mutations on the aggregation and chápenme 
activity of α A-crystallin is described. Evidence is found that certain hydrophobic residues 
are involved in intersubunit interactions. Since the mutated residues are located in both 
protein domains, the aggregation capacity cannot be ascribed simply to one protein 
domain. An evolutionary well-conserved charged residue was found to be important for 
the structure and chaperone-activity of orA-crystallin. 
Finally, anti-crystallin antibodies in the serum of patients with cataract were identified 
(Chapter 6). It turned out that the immune-system is tolerant for exactly those crystallina 
that occur extra-lenticularly (aA-, aB- and 0B2-crystallin). 
SAMENVATTING 
De ooglens breekt het invallend licht en is geheel transparant. Om de werking van de 
ooglens beter te kunnen begrijpen is het van belang de structuur te kennen van de 
elementen waaruit de lens is opgebouwd. De belangrijkste eiwitcomponenten van de lens 
zijn de crystallines. In de lenzen van veel vertebraten komt α-crystalline in grote 
hoeveelheden voor. α-Crystalline vormt grote eiwitcomplexen, die zijn opgebouwd uit 
twee typen polypeptideketens, aA- en aB-crystalline. Het oplossen van de ruimtelijke 
structuur van α-crystalline wordt van steeds groter belang, gezien de ontwikkelingen van 
de laatste 10 jaar. Ontdekt werd dat α-crystalline tot dezelfde eiwitfamilie behoort als de 
kleine 'heat shock'-eiwitten (HSPs). Deze eiwitten worden verondersteld een belangrijke 
rol te spelen in het overlevingsproces van organismen, nadat ze aan stress zijn 
blootgesteld. Bovendien is ontdekt dat beide a-crystallineketens ook in diverse weefsels 
buiten de lens voorkomen. De expressie van aB-crystalline wordt verhoogd onder stress­
condities. Bovendien is het nivo van aB-crystalline verhoogd bij degeneratieve 
afwijkingen van bepaalde organen. Tevens heeft men gevonden dat α-crystalline in vitro 
zich als een moleculaire chaperonne kan gedragen. Het ophelderen van de drie­
dimensionale structuur van α-crystalline kan dus ook een bijdrage leveren aan een beter 
begrip van de functie van de leden van de eiwitfamilie van α-crystalline en de kleine 
HSPs. Het ligt voor de hand dat de opbouw van de aggregaten van α-crystalline en de 
kleine HSPs essentieel is voor hun functie. Dit proefschrift gaat daarom vooral in op deze 
'quaternaire' structuur van α-crystalline. Daarnaast wordt de relatie tussen structuur en 
functie van α-crystalline en de kleine HSPs verduidelijkt. 
In hoofdstuk 2 wordt een studie beschreven waarin eigenschappen van het kleine 'heat 
shock'-eiwit van de muis (HSP25) wordt vergeleken met die van α-crystalline, met het 
doel het inzicht in structurele en functionele overeenkomsten te vergroten. Eén van de 
eigenschappen van α-crystalline is het vermogen om zich als een moleculaire eh orme 
te gedragen. Dit zijn eiwitten die voorkómen dat andere eiwitten een verkeerde .tuur 
aannemen of die een eenmaal verkeerd gevouwen eiwit, dat bijvoorbeeld ontstaan is na 
een hitte-schok, ontwarren. Aangetoond werd dat ook HSP2S zich als een moleculaire 
chaperonne kan gedragen. HSP2S beschermt namelijk j9L-crystalline tegen hitte-
geïnduceerde denaturatie. Verder is aangetoond dat HSP25 een efficiënte inhibitor van 
elastase is en dat het een substraat is voor transglutaminase, evenals aB-crystalline. 
Aannemelijk werd gemaakt dat α-crystalline en de kleine HSPs vergelijkbare structuren 
hebben: de secundaire structuren lijken op elkaar, beide eiwitten zijn even stabiel wanneer 
ze met ureum worden gedissociêerd en elke combinatie van eiwitketens (aA, aB of 
HSP2S) levert een aggregaat van de juiste grootte op. 
De eiwitketens van α-crystalline en de kleine HSP-ketens zijn waarschijnlijk opgebouwd 
uit twee globulaire domeinen en een uitstekend C-terminaal staartje (hoofdstuk 1, ref. 30). 
Het C-terminale domein, dat de best geconserveerde sequentie van de eiwitfamilie is, 
wordt verondersteld het 'aggregatie-domein' te zijn. Om deze hypothese te testen werden 
het N-terminale domein en het C-terminale domein met staartje van aA-crystalline 
geïsoleerd en onderzocht op aggregatiegedrag. Deze studie is beschreven in hoofdstuk 3. 
Het bleek dat het C-terminale domein met staartje (aA2Dt) dimeren of tetrameren vormt. 
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Het N-teiminale domein daarentegen heeft een moelijk definieerbare multimere vorm. Om 
het belang van het geconserveerde C-terminale domein met staartje verder te onderzoeken 
zijn ook de overeenkomstige fragmenten van aB-crystalline (aB2Dt) en HSP25 (HSP2Dt) 
geïsoleerd. Vervolgens is de secundaire en quaternaire structuur van deze eiwitfragmenten 
onderzocht (Hoofdstuk 4). aA2Dt, aB2Dt en HSP2Dt hebben een secundaire structuur 
die sterk lijkt op de eiwitten waarvan ze zijn afgeleid. Ze bestaan voornamelijk uit 'ß-
pleated sheets' en bevatten weinig of geen α-helix. Dit stemt overeen met de 
veronderstelling dat de structuur van de α-crystalline en kleine HSP-polypeptideketens uit 
twee domeinen bestaat, met twee gelijkende structurele motieven. Daarnaast is de 
secundaire structuur van het C-terminale deel van de onderzochte leden van de 
eiwitfamilie goed geconserveerd, net zo als de primaire structuur. aB2Dt en HSP2Dt 
vormen grote aggregaten, hetgeen in tegenstelling lijkt te zijn met het aggregatiegedrag 
van aA2Dt. Hoogst waarschijnlijk echter zijn deze aggregaten opgebouwd uit dimere of 
tetramere eenheden. De resultaten worden beschouwd in overeenstemming te zijn met het 
rhombododecahedron model voor de quaternaire structuur van α-crystalline en de kleine 
HSPs (hoofdstuk 1, ref. 139). 
In hoofdstuk 5 wordt het effect van enkele puntmutaties op het aggregatie- en chaperon­
negedrag van aA-crystalline beschreven. Er zijn aanwijzingen gevonden dat bepaalde 
hydrofobe residuen betrokken zijn bij interacties tussen de polypeptideketens. Aangezien 
de gemuteerde residuen zich in beide eiwitdomeinen bevinden, kan het vermogen om 
aggregaten te vormen niet aan slechts één domein worden toegekend. Een geladen residu 
dat goed geconserveerd is gebleven tijdens de evolutie, bleek belangrijk te zijn voor de 
structuur en de chaperonne-activiteit van aA-crystalline. 
Tenslotte werden antilichamen tegen crystallines in het serum van patiënten met cataract 
geïdentificeerd (Hoofdstuk 6). Daaruit bleek dat het immuunsysteem tolerant is voor juist 
die crystallines die ook buiten de lens voorkomen (aA-, aB- en 0B2-crystalline). 
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